Data / Research funding / Regenerative Medicine
Regenerative Medicine: 4,397 NIH awards ($4.5B) to 515 organizations
4,397 NIH awards ($4.5B) in the NIH spending category Regenerative Medicine, to 515 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 4,397 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Blood and Marrow Transplant Clinical Trials Network DCC- The Medical College of Wisconsin, Inc. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $36,418,175 | September 15, 2017 | August 31, 2031 | HAMADANI, MEHDI HUSSAIN | reporter.nih.gov |
| A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research | NIH | National Cancer Institute | 2021 to 2025 | $30,268,190 | March 1, 1998 | February 29, 2028 | SHAW, BRONWEN | reporter.nih.gov |
| Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial | NIH | National Institute on Aging | 2021 to 2025 | $28,784,116 | August 15, 2019 | April 30, 2027 | BRINTON, ROBERTA EILEEN | reporter.nih.gov |
| Center for Dental, Oral, and Craniofacial Tissue and Organ Regeneration (C-DOCTOR) | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $25,635,194 | May 7, 2020 | April 30, 2026 | CHAI, YANG | reporter.nih.gov |
| Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center: Advancing Dental, Oral, and Craniofacial Regeneration to Clinical Trial Initiation | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $24,937,885 | May 1, 2020 | April 30, 2026 | KOHN, DAVID H. | reporter.nih.gov |
| Idaho INBRE Program | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $21,939,274 | September 30, 2001 | August 31, 2030 | BOHACH, CAROLYN HOVDE | reporter.nih.gov |
| Parkinsons Disease Scalable iPSC Autologous Cell Therapy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $7,528,144 | January 1, 2020 | December 31, 2025 | HALLETT, PENELOPE JANE | reporter.nih.gov |
| TRANSPIRE: A Prospective Cohort Study of Lung Injury After Hematopoietic Stem Cell Transplant in Children. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,251,380 | September 1, 2021 | May 31, 2027 | DAVIES, STELLA MARGARET | reporter.nih.gov |
| Exosomes as mediators of cardiac injury and repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,022,243 | September 1, 2017 | June 30, 2029 | KISHORE, RAJ | reporter.nih.gov |
| Chemical, Structural and Cell-Signaling Interrogation of 15-Prostanglandin Dehydrogenase in Tissue Repair and Regeneration | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $6,903,660 | June 1, 2021 | May 31, 2026 | READY, JOSEPH M | reporter.nih.gov |
| Tissue Engineering Resource Center | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2025 | $6,721,905 | September 16, 2019 | February 28, 2029 | VUNJAK-NOVAKOVIC, GORDANA | reporter.nih.gov |
| An Intranasal GDNF Gene Therapy for Opioid Relapse Reduction | NIH | National Institute on Drug Abuse | 2021 | $6,693,512 | September 15, 2021 | August 31, 2025 | WASZCZAK, BARBARA LEE | reporter.nih.gov |
| Molecular Circuits in the Hematopoietic Stem Cell Niche | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $6,422,507 | August 15, 2020 | May 31, 2025 | DALEY, GEORGE Q | reporter.nih.gov |
| Mentoring Research Excellence in Aging and Regenerative Medicine | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $6,297,053 | June 1, 2022 | May 31, 2027 | JAZWINSKI, S MICHAL | reporter.nih.gov |
| Restoration of Grasp and Reach in Cervical Spinal Cord Injury | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $5,968,318 | March 1, 2018 | August 31, 2025 | KILGORE, KEVIN L. | reporter.nih.gov |
| Novel Biologic Therapies for GVHD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,851,412 | February 1, 2010 | June 30, 2026 | KEAN, LESLIE S | reporter.nih.gov |
| Accelerating photoreceptor replacement therapy with in-vivo cellular imaging of retinal function | NIH | National Eye Institute | 2021 to 2025 | $5,733,511 | September 30, 2021 | January 31, 2027 | MCGREGOR, JULIETTE ELIZABETH | reporter.nih.gov |
| Overcoming Neurogenic “Meta-Inflammation” to Promote Recovery After Spinal Cord Injury | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $5,600,627 | May 1, 2019 | April 30, 2027 | POPOVICH, PHILLIP G | reporter.nih.gov |
| A Human iPSC-based Cell Therapy for Canavan Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $5,276,950 | June 15, 2021 | May 31, 2027 | SHI, YANHONG | reporter.nih.gov |
| Continuous Neurogenesis in the Mammalian Hippocampus | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $5,244,633 | May 1, 2020 | April 30, 2028 | SONG, HONGJUN | reporter.nih.gov |
| Fecal Microbiota Transplantation and Fiber for the Treatment of Graft-versus-host Disease After Hematopoietic Cell Transplantation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $5,128,451 | September 1, 2023 | June 30, 2027 | FREDRICKS, DAVID NEAL | reporter.nih.gov |
| Novel Strategies to Improve Blood Transfusion Practice | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $5,119,758 | August 15, 2022 | July 31, 2027 | LUO, HONGBO R | reporter.nih.gov |
| A Precision Medicine Approach for the Study of Targetable Pathways in Vascular Dementia | NIH | National Institute on Aging | 2022 to 2025 | $5,086,657 | February 1, 2022 | November 30, 2026 | GOATE, ALISON M | reporter.nih.gov |
| Adaptable tissue-specific endothelial cells for organ regeneration | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,071,342 | April 1, 2020 | March 31, 2027 | RAFII, SHAHIN | reporter.nih.gov |
| Human gene transfer & macrophage cell transplantation therapy of hereditary PAP (hPAP) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $5,061,587 | May 10, 2021 | April 30, 2027 | TRAPNELL, BRUCE C | reporter.nih.gov |
| Dietary Restriction, GH/IGF-1 & Mechanisms of Cellular Protection and Regeneration | NIH | National Institute on Aging | 2021 to 2023 | $5,057,227 | February 15, 2018 | January 31, 2024 | LONGO, VALTER D. | reporter.nih.gov |
| Mucus-degrading intestinal bacteria and toxicities of hematopoietic cell transplantation | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $5,032,505 | September 21, 2024 | July 31, 2029 | JENQ, ROBERT | reporter.nih.gov |
| 1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $5,023,972 | April 1, 2022 | March 31, 2029 | SHAW, BRONWEN | reporter.nih.gov |
| Center for Modular Manufacturing of Structural Tissues | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2025 | $4,984,439 | June 1, 2016 | May 31, 2027 | WELTER, JEAN F | reporter.nih.gov |
| Investigating the heterogeneity and coordination of hematopoietic stem cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,840,269 | August 1, 2020 | July 31, 2027 | LU, RONG | reporter.nih.gov |
| Program to promote lung regeneration and block fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,819,926 | February 15, 2020 | February 14, 2026 | CHAPMAN, HAROLD A | reporter.nih.gov |
| Novel Stem Cell Immunotherapy for MDR-Tuberculosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,800,190 | June 4, 2021 | May 31, 2026 | JAGANNATH, CHINNASWAMY | reporter.nih.gov |
| A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory Antibodies | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $4,780,411 | April 5, 2019 | March 31, 2026 | WILCOX, DAVID ALLEN | reporter.nih.gov |
| Defining mechanisms driving salivary gland regeneration | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $4,717,861 | September 18, 2018 | June 30, 2026 | KNOX, SARAH MONICA | reporter.nih.gov |
| Altering Cardiac Cell Fate for Heart Repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,621,749 | January 13, 2021 | November 30, 2027 | QIAN, LI | reporter.nih.gov |
| Cell signaling in development and regeneration | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $4,582,546 | May 6, 2016 | July 9, 2026 | JIANG, JIN | reporter.nih.gov |
| Completion of Non-clinical long-term GLP safety and GMP manufacture for first-in-class neuron regenerative therapy, NNI-362 Phase 2 POC AD trial | NIH | National Institute on Aging | 2023 to 2024 | $4,543,556 | September 1, 2023 | August 31, 2025 | KELLEHER-ANDERSSON, JUDITH A | reporter.nih.gov |
| A nonhuman primate model of stem cell transplantation to understand determinants of post-transplant SIV clearance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,411,202 | December 21, 2016 | June 30, 2026 | SACHA, JONAH B. | reporter.nih.gov |
| Cell-cell interactions governing lung epithelial progenitor cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,407,300 | March 15, 2020 | January 31, 2027 | KIM, CARLA F. | reporter.nih.gov |
| Progenitor Regulation in Craniofacial Development and Regeneration | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $4,376,497 | September 14, 2017 | June 30, 2026 | CRUMP, GAGE D | reporter.nih.gov |
| Elucidating Mechanism of Cardiac Fibrosis with Cell Village of Pooled Human iPSCs | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,345,357 | December 16, 2015 | May 31, 2028 | WU, JOSEPH C. | reporter.nih.gov |
| A generalizable framework for linking single-cell genomic states with cell fate outcomes in hematopoiesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $4,203,696 | August 15, 2020 | May 31, 2025 | GRIMES, H. LEIGHTON | reporter.nih.gov |
| Small molecule targeting an epigenetic regulator for the treatment of osteoarthritis | NIH | National Institute on Aging | 2021 to 2024 | $4,178,124 | September 30, 2021 | May 2, 2025 | ADORNO, MADDALENA | reporter.nih.gov |
| Genome-Wide Discovery and Translational Research for Neural Repair | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $4,147,990 | December 1, 2016 | November 30, 2025 | STRITTMATTER, STEPHEN M | reporter.nih.gov |
| Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,065,243 | March 15, 2021 | February 28, 2027 | DEBAUN, MICHAEL R. | reporter.nih.gov |
| Base editing and prime editing for sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,000,055 | January 1, 2021 | June 30, 2030 | WEISS, MITCHELL J | reporter.nih.gov |
| Consortium on Intestinal Regeneration and Fetal Reversion: from Atlas to Therapy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $4,000,000 | September 1, 2024 | June 30, 2029 | KLEIN, OPHIR D | reporter.nih.gov |
| Impact of chronic alcohol consumption on the functional and epigenetic landscapes of monocytes and their progenitors | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $3,998,523 | September 1, 2020 | August 31, 2029 | MESSAOUDI, ILHEM | reporter.nih.gov |
| Combining Targeted RIT and Synergistic Novel Agent-Renewal | NIH | National Cancer Institute | 2021 to 2025 | $3,984,924 | June 1, 2020 | May 31, 2027 | OROZCO, JOHNNIE JOSE | reporter.nih.gov |
| Engineered Stem Cells for Cardiac Repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,984,462 | February 1, 2018 | March 31, 2027 | REGNIER, MICHAEL | reporter.nih.gov |
| BIOREPOSITORY OF HUMAN INDUCED PLURIPOTENT STEM CELLSFORCARDIOVASCULAR DISEASES (BHIPSC-CVD)- TASK A. CORE STUDY OPERATIONS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,969,819 | September 1, 2020 | August 31, 2025 | WU, JOSEPH | reporter.nih.gov |
| Mesenchymal Vascular Progenitor Depletion Promotes Lung Aging and Susceptibility to Emphysema | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,964,079 | January 1, 2022 | December 31, 2028 | MAJKA, SUSAN M | reporter.nih.gov |
| Pulmonary Valved Graft with Regeneration Potential for Pediatric Patients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,958,584 | May 24, 2019 | February 28, 2027 | HOUDE, AJAY | reporter.nih.gov |
| Synergistic white matter injury from diesel exhaust particulate and chronic cerebral hypoperfusion exposures: Interaction between the Nogo/NgR1 receptor pathway and extravascular fibrinogen toxicity | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $3,929,367 | September 20, 2022 | August 31, 2027 | MACK, WILLIAM J | reporter.nih.gov |
| Cardiac lineage determination and nuclear architecture | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,927,168 | January 1, 2018 | December 31, 2024 | EPSTEIN, JONATHAN A. | reporter.nih.gov |
| Hematopoietic stem and progenitor cell regulation for enhanced clinical efficacy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,911,609 | August 1, 2015 | July 31, 2028 | KAPUR, REUBEN | reporter.nih.gov |
| Study of cell-type specific Alzheimer's disease genetic variants using a novel bioengineered model of iPSC-derived neural tissue | NIH | National Institute on Aging | 2021 to 2024 | $3,903,556 | May 1, 2020 | April 30, 2026 | TESCO, GIUSEPPINA | reporter.nih.gov |
| Characterizing Wnt Signaling Pathways in Axon Guidance | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,896,283 | June 15, 2023 | May 31, 2026 | ZOU, YIMIN | reporter.nih.gov |
| Multicellular Mechanisms Driving Axon Regeneration | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,884,176 | May 17, 2021 | April 30, 2029 | CAVALLI, VALERIA | reporter.nih.gov |
| Human iPSCs for Elucidating Intercellular Crosstalk Signaling in Dilated Cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,869,226 | May 1, 2018 | May 31, 2027 | WU, JOSEPH C. | reporter.nih.gov |
| Multi-center Evaluation of the Threat of Established and Emerging Respiratory Viral Infections in Pediatric Transplant Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,866,357 | September 17, 2021 | August 31, 2027 | STEINBACH, WILLIAM J | reporter.nih.gov |
| T cells in the aging brain | NIH | National Institute on Aging | 2021 to 2025 | $3,850,998 | June 15, 2021 | March 31, 2027 | BRUNET, ANNE | reporter.nih.gov |
| Understanding Skin Tissue Repair in Live Mammals | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,829,886 | March 1, 2018 | August 31, 2027 | GRECO, VALENTINA | reporter.nih.gov |
| The role of hypoxia in venous neointimal hyperplasia in hemodialysis grafts | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,815,411 | February 1, 2010 | April 30, 2028 | MISRA, SANJAY | reporter.nih.gov |
| Vascular Growth and Regeneration | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,813,801 | February 7, 2018 | August 31, 2024 | IRUELA-ARISPE, M. LUISA | reporter.nih.gov |
| Cell competition in pulmonary fibrosis and ARDS | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,796,920 | August 20, 2022 | July 31, 2029 | DE LANGHE, STIJN PIET JOHAN | reporter.nih.gov |
| A two-pronged approach to generating novel models of photoreceptor degeneration for regenerative cell therapy | NIH | National Eye Institute | 2021 to 2024 | $3,781,701 | September 30, 2021 | July 31, 2026 | FU, YINGBIN | reporter.nih.gov |
| Modulating Glial Fate and Function in Development and Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,751,910 | May 1, 2020 | April 30, 2028 | TESAR, PAUL JOSEPH | reporter.nih.gov |
| Live Imaging of Skin Regeneration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,713,235 | September 7, 2012 | August 31, 2027 | GRECO, VALENTINA | reporter.nih.gov |
| Novel therapeutic gene editing to induce fetal hemoglobin for sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,710,340 | September 1, 2023 | August 31, 2028 | WEISS, MITCHELL J | reporter.nih.gov |
| Elucidating the Biological Differences Between Distinct Fibrillar and Non-Fibrillar Alpha-Synuclein Inclusions in Human Stem-Cell Models | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $3,706,946 | July 1, 2020 | April 30, 2026 | KHURANA, VIKRAM | reporter.nih.gov |
| Stimulation of novel spinal respiratory circuit to restore breathing in ventilator-dependent patients with SCI. | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,702,825 | August 1, 2021 | December 31, 2027 | LU, DANIEL | reporter.nih.gov |
| Harnessing the therapeutic potential of neural crest cells by manipulating the primary cilium | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $3,694,614 | September 14, 2017 | June 30, 2025 | BRUGMANN, SAMANTHA A | reporter.nih.gov |
| THE USE OF FIBRIN HYDROGELS TO PROMOTE SALIVARY GLAND REGENERATION | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,689,371 | July 16, 2012 | May 31, 2027 | BAKER, OLGA JULIANA | reporter.nih.gov |
| Optimizing Hematopoietic Stem Cell Transplantation For The Treatment Of Hematological Malignancies | NIH | National Cancer Institute | 2021 to 2025 | $3,687,540 | September 7, 2017 | June 30, 2032 | DIPERSIO, JOHN F. | reporter.nih.gov |
| Tissue-engineered trachea composites for long-segment airway replacement | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,672,010 | July 16, 2021 | June 30, 2027 | CHIANG, TENDY | reporter.nih.gov |
| Regulation of cell growth and proliferation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,670,469 | May 1, 2021 | April 30, 2027 | EDGAR, BRUCE ALEXANDER | reporter.nih.gov |
| Targeting Cell-Type Specific Disease Phenotypes to Promote CNS Repair | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $3,654,519 | August 1, 2023 | April 30, 2028 | LEE, JAE K | reporter.nih.gov |
| Improving Tissue Engineered Vascular Graft Performance via Computational Modeling | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,638,571 | January 1, 2018 | March 31, 2027 | BREUER, CHRISTOPHER KANE | reporter.nih.gov |
| Bioengineering Center for Regeneration and Formation of Tissues (SC BioCRAFT) | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $3,635,427 | July 1, 2019 | June 30, 2025 | VYAVAHARE, NAREN R | reporter.nih.gov |
| Oocyte polarity and BMP-mediated dorsoventral patterning | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,633,141 | June 1, 2019 | May 31, 2029 | MULLINS, MARY C. | reporter.nih.gov |
| Intranasal Treatment of Stem Cell-derived Extracellular Vesicles for Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $3,620,000 | August 1, 2022 | July 31, 2027 | SHETTY, ASHOK K | reporter.nih.gov |
| HCMV-induced innate-like CD8 T cells and allogeneic HCT outcome | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,601,018 | April 9, 2021 | March 31, 2027 | HSU, KATHARINE C | reporter.nih.gov |
| New technologies to identify molecular regulators of the human hippocampus neurogenic niche in healthy aging and Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $3,598,243 | May 15, 2022 | February 28, 2027 | DUPONT, MAURA BOLDRINI | reporter.nih.gov |
| Human iPSC Model to Elucidate Metabolic Interplay in Diabetic Cardimyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,569,593 | April 1, 2019 | April 30, 2027 | WU, JOSEPH C. | reporter.nih.gov |
| Reprogramming of mature SMCs to vascular progenitor cells: Focus on Vascular Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,548,396 | January 18, 2019 | June 30, 2027 | WEISER-EVANS, MARY CM | reporter.nih.gov |
| Ocular Immune Regulation by Mesenchymal Stem Cells | NIH | National Eye Institute | 2021 to 2025 | $3,542,949 | April 1, 2015 | September 14, 2028 | CHAUHAN, SUNIL K | reporter.nih.gov |
| Molecular Mechanisms Controlling Lymphatic Vascular Function in Health and Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,522,987 | July 5, 2016 | May 31, 2027 | CHEN, HONG | reporter.nih.gov |
| 1/2 Allogeneic Human Mesenchymal Stem Cell (MSC) Injection in Patients with Hypoplastic Left Heart Syndrome: A Phase IIb Clinical Trial | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,521,212 | September 15, 2020 | August 31, 2025 | BERGER, STUART | reporter.nih.gov |
| Mechanisms of Alveolar Homeostasis, Injury, Regeneration, and Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,471,063 | March 1, 2022 | February 28, 2029 | ZEMANS, RACHEL LYNNE | reporter.nih.gov |
| Intensive tailored exercise training with NAD+ precursor supplementation to improve muscle mass and fitness in adolescent and young adult survivors of hematopoietic stem cell transplantation | NIH | National Cancer Institute | 2021 to 2025 | $3,469,202 | September 1, 2021 | August 31, 2027 | MOSTOUFI-MOAB, SOGOL | reporter.nih.gov |
| Molecular genetics of axon and synapse development and maintenance | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $3,460,604 | May 1, 2022 | April 30, 2030 | JIN, YISHI | reporter.nih.gov |
| Randomized trial of viral specific T-cell infusion to prevent viral infection after hematopoietic stem cell transplant. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,457,708 | July 1, 2021 | April 30, 2027 | DAVIES, STELLA MARGARET | reporter.nih.gov |
| Immunobiology of Lung Injury and Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,455,443 | January 21, 2019 | December 31, 2024 | MOORE, BETHANY B. | reporter.nih.gov |
| Leveraging zebrafish models to dissect and enhance heart regeneration | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,454,465 | May 15, 2020 | December 31, 2024 | POSS, KENNETH D | reporter.nih.gov |
| Biomaterials-directed regenerative immunotherapies | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $3,438,750 | September 25, 2019 | August 31, 2025 | ELISSEEFF, JENNIFER H | reporter.nih.gov |
| The Impact of the Bone Marrow Niche's Immune Privilege on Psoriatic Arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,406,145 | August 8, 2025 | July 31, 2029 | FUJISAKI, JOJI | reporter.nih.gov |
| Remediating fibrosis for salivary gland regeneration | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,392,837 | April 1, 2019 | March 31, 2029 | LARSEN, MELINDA | reporter.nih.gov |
| Developmental origins and homeostatic mechanisms underlying adult phenotypes | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,384,344 | May 1, 2017 | April 30, 2027 | PARICHY, DAVID M | reporter.nih.gov |
| Gene therapy for SCID-X1 with low dose busulfan and a SIN-lentiviral vector | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,369,470 | July 7, 2016 | December 31, 2029 | WILLIAMS, DAVID A | reporter.nih.gov |
| Cochlear synaptopathy in noise-induced and age-related hearing loss: mechanisms and treatments | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $3,352,414 | April 1, 1982 | February 29, 2028 | LIBERMAN, M. CHARLES | reporter.nih.gov |
| Cellular and molecular mechanisms underlying DDX3X syndrome | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,350,844 | January 1, 2021 | November 30, 2026 | SILVER, DEBRA L. | reporter.nih.gov |
| Dystrophin Replacement | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,349,499 | April 1, 1991 | April 30, 2026 | CHAMBERLAIN, JEFFREY S | reporter.nih.gov |
| Regulation of Progenitor Cell Plasticity in Lung Development and Disease-Repair | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,331,553 | July 1, 2023 | June 30, 2030 | CARDOSO, WELLINGTON V. | reporter.nih.gov |
| Hydrogels for human beta cell survival, function and evasion of immune rejection | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,331,035 | September 15, 2022 | May 31, 2027 | GARCIA, ANDRES J | reporter.nih.gov |
| The Primate Corticospinal Connectome and Transcriptome | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,321,910 | September 15, 2017 | May 31, 2026 | TUSZYNSKI, MARK H. | reporter.nih.gov |
| Leveraging 3D bioprinted organoid constructs to pattern and model human brain development | NIH | National Institute of Mental Health | 2021 to 2025 | $3,321,612 | April 1, 2021 | January 31, 2026 | SLOAN, STEVEN A | reporter.nih.gov |
| Genetic control of developmental timing | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,305,251 | May 1, 2019 | January 31, 2030 | AMBROS, VICTOR | reporter.nih.gov |
| Angiogenic growth factor delivery for vascular regeneration in critical limb ischemia using acoustically-responsive scaffolds | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,303,433 | December 15, 2017 | November 30, 2027 | FABIILLI, MARIO LEONARDO | reporter.nih.gov |
| Vascular Dysfunction in Myocardial Ischemia and Metabolic Syndrome | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,258,608 | April 1, 2016 | June 30, 2027 | SELLKE, FRANK W | reporter.nih.gov |
| Identification of enteric Juvenile Protective Factors and their role in stimulating neurogenesis in the adult and ageing Enteric Nervous System | NIH | National Institute on Aging | 2021 to 2025 | $3,254,354 | January 15, 2021 | December 31, 2026 | GOFF, LOYAL ANDREW | reporter.nih.gov |
| Genetic and Molecular Dissection of Wnt Pathway Activation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,246,880 | June 1, 2020 | July 31, 2030 | AHMED, YASMATH | reporter.nih.gov |
| A spatial view of hematopoietic regeneration dynamics in the bone marrow | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $3,245,428 | September 15, 2024 | July 31, 2029 | LU, RONG | reporter.nih.gov |
| Genetically Diverse Mouse Embryonic Stem Cells: A Platform for Cellular Systems Genetics | NIH | Office of the Director, National Institutes of Health | 2021 to 2024 | $3,241,681 | March 1, 2021 | May 31, 2025 | REINHOLDT, LAURA G | reporter.nih.gov |
| Telemetric Regenerative Bandage for Accelerating Wound Healing | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,240,738 | September 24, 2021 | July 31, 2027 | AMEER, GUILLERMO ANTONIO | reporter.nih.gov |
| Mechanisms of specification, quiescence, and regeneration of primordial germ cells | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,240,052 | June 1, 2021 | September 30, 2026 | WESSEL, GARY M | reporter.nih.gov |
| Developing second generation SCID pig models: filling the gaps to improve translation of therapeutics in regenerative medicine | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $3,219,338 | February 15, 2020 | July 31, 2029 | TUGGLE, CHRISTOPHER | reporter.nih.gov |
| Protecting colonic mucus to mitigate acute intestinal graft-versus-host disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,218,917 | August 15, 2015 | June 30, 2026 | JENQ, ROBERT | reporter.nih.gov |
| The epigenetic regulation of inflammation in tissue repair and vascular disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,217,378 | July 1, 2023 | June 30, 2030 | GALLAGHER, KATHERINE ANN | reporter.nih.gov |
| Regulation of Epidermal Development and Differentiation-Renewal | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,204,420 | January 1, 1983 | May 31, 2026 | FUCHS, ELAINE | reporter.nih.gov |
| Reprogramming and Directed Differentiation of Skeletal Muscle Cells from hPSCs | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,204,262 | September 20, 2013 | June 30, 2028 | PYLE, APRIL D | reporter.nih.gov |
| Cell specific delivery of novel therapies to enhance glomerular regeneration and repair | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,199,320 | September 1, 2020 | May 31, 2025 | SHANKLAND, STUART JAMES | reporter.nih.gov |
| Technology-Enabled Activation of Skin Cancer Screening for Hematopoietic Cell Transplantation Survivors and their Primary Care Providers | NIH | National Cancer Institute | 2021 to 2024 | $3,192,137 | April 1, 2020 | March 31, 2026 | ARMENIAN, SARO | reporter.nih.gov |
| Human Umbilical Cord as a Regenerative Meningeal Patch to Prevent Tethering and Improve Neurological Function Following In-Utero Spina Bifida Repair | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,190,303 | April 1, 2021 | February 28, 2027 | PAPANNA, RAMESHA | reporter.nih.gov |
| Regulation of Growth and Morphogenesis | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,183,036 | May 1, 2019 | April 30, 2029 | IRVINE, KENNETH D | reporter.nih.gov |
| Developing a bioprinted ventilated lung alveolar platform for investigating microbial interactions and influenza response | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,182,827 | August 19, 2025 | July 31, 2029 | OH, JULIA | reporter.nih.gov |
| Tissue Engineering and Regeneration | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,182,470 | July 1, 1976 | June 30, 2027 | KOHN, DAVID H. | reporter.nih.gov |
| Developing preclinical xenograft models in zebrafish. | NIH | Office of the Director, National Institutes of Health | 2022 to 2025 | $3,178,512 | March 1, 2022 | February 28, 2026 | LANGENAU, DAVID MICHAEL | reporter.nih.gov |
| Autologous BM-MSCs and Islet Co-transplantation to Enhance Islet Survival and Function in TP-IAT Patients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,169,762 | August 24, 2021 | May 31, 2027 | WANG, HONGJUN | reporter.nih.gov |
| Hematopoietic Stem Cell And Cord Blood Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,169,146 | September 30, 2005 | May 31, 2030 | PETERSDORF, EFFIE W | reporter.nih.gov |
| Next Generation Therapies for Fertility Preservation in Male Cancer Patients | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $3,165,939 | May 15, 2020 | April 30, 2025 | ORWIG, KYLE EDWIN | reporter.nih.gov |
| Cellular Reinnervation Therapy for Vocal Fold Paralysis | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $3,161,418 | August 4, 2021 | May 31, 2027 | HALUM, STACEY L. | reporter.nih.gov |
| Ex Vivo Generation of Functional Kidney Tissues for Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,161,308 | September 1, 2020 | May 14, 2025 | LEWIS, JENNIFER A. | reporter.nih.gov |
| Engineering Vascularized Cardiac Muscle | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,149,452 | July 1, 2005 | March 31, 2027 | VUNJAK-NOVAKOVIC, GORDANA | reporter.nih.gov |
| Supply and Demand: Oxygen and Workload Regulate Cardiomyocyte Proliferation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,145,077 | February 15, 2023 | February 28, 2025 | SADEK, HESHAM | reporter.nih.gov |
| Molecular control of cardiac regenerative potential | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,142,578 | December 1, 2017 | December 31, 2026 | HUANG, GUO | reporter.nih.gov |
| Harnessing Novel Human Endocrine Progenitor Biology for Enhanced Generation of Beta Cells from Stem Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $3,140,632 | September 1, 2025 | August 31, 2029 | SNEDDON, JULIE BETH | reporter.nih.gov |
| Preclinical Assessment of a Compliance Matched Biopolymer Vascular Graft | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,139,611 | December 15, 2021 | November 30, 2026 | VANDE GEEST, JONATHAN PIETER | reporter.nih.gov |
| Cellular Therapy for Type 1 Diabetes using Mesenchymal Stem Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,134,067 | June 1, 2019 | March 31, 2027 | WANG, HONGJUN | reporter.nih.gov |
| Modeling intestinal dysfunction in HIV infection with organoid technology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $3,127,465 | January 10, 2020 | December 31, 2025 | OTT, MELANIE MARIA | reporter.nih.gov |
| Parametric Response Mapping (PRM) for the detection of chronic lung injury in hematopoietic cell transplant recipients | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,121,383 | August 15, 2022 | July 31, 2026 | YANIK, GREGORY A | reporter.nih.gov |
| Gvl mHA Specific T Cell Responses Prevent AML Relapse Following Allogeneic Stem Cell Transplantation. | NIH | National Cancer Institute | 2021 to 2025 | $3,119,515 | July 1, 2020 | June 30, 2027 | VINCENT, BENJAMIN G | reporter.nih.gov |
| Penetrating the “Black box”: Prediction of early Bronchiolitis obliterans in Pediatric Hematopoietic Stem Cell Transplant Recipients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,117,523 | July 15, 2021 | April 30, 2027 | MYERS, KASIANI | reporter.nih.gov |
| Neural stem cell rejuvenation through single cell pharmacogenomics | NIH | National Institute on Aging | 2022 to 2025 | $3,117,021 | June 15, 2022 | February 28, 2027 | BONAGUIDI, MICHAEL | reporter.nih.gov |
| Integrating TPM and PAM to examine the metabolic underpinning of neurovascular repair after stroke | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,104,362 | September 1, 2021 | June 30, 2026 | HU, SONG | reporter.nih.gov |
| Mechanisms that couple irregular development of fetal melanoblasts to premature exhaustion of adult melanocyte stem cells | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,102,648 | August 4, 2021 | May 31, 2027 | ADAMS, PETER D. | reporter.nih.gov |
| Engineering Injectable Microporous Hydrogels for Diabetic Wound Repair | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,099,608 | August 2, 2021 | June 30, 2027 | GRIFFIN, DONALD RICHIERI | reporter.nih.gov |
| Vascularized NICHE with local immunosuppression for cell replacement for Type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $3,096,729 | September 12, 2022 | May 31, 2027 | GRATTONI, ALESSANDRO | reporter.nih.gov |
| Mouse and human vestibular regeneration and function | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $3,090,473 | December 1, 2018 | November 30, 2028 | CHENG, ALAN GI-LUN | reporter.nih.gov |
| Resolution of inflammation in healing myocardial infarcts | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,081,125 | January 15, 2008 | December 31, 2026 | FRANGOGIANNIS, NIKOLAOS G | reporter.nih.gov |
| Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,081,124 | January 16, 2020 | December 31, 2024 | YANG, OTTO O | reporter.nih.gov |
| Harnessing natural stem cell-based strategies for mammalian dental renewal | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $3,080,448 | September 22, 2016 | June 30, 2024 | KLEIN, OPHIR D | reporter.nih.gov |
| Spinal Reflex Conditioning System for Enhancing Motor Function Recovery After Incomplete Spinal Cord Injury | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $3,077,317 | September 30, 2020 | December 31, 2026 | CLEMENTS, ISAAC PERRY | reporter.nih.gov |
| Chemical and Physical Mechanisms of Wound Detection | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,076,041 | May 1, 2021 | April 30, 2026 | NIETHAMMER, PHILIPP MICHAEL | reporter.nih.gov |
| Anti-inflammatory Cell Based Repair of Intervertebral Disc Degeneration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,075,117 | September 1, 2021 | August 31, 2026 | CHAHINE, NADEEN O. | reporter.nih.gov |
| BIOLOGICAL EMBEDDING OF CONTEXTUAL FACTORS IN HUMAN STEM CELLS: IMPLICATIONS FOR POPULATION HEALTH DIFFERENCES | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $3,074,250 | September 26, 2022 | June 30, 2027 | WADHWA, PATHIK D | reporter.nih.gov |
| Mechanism of stathmin-2-dependent axon maintenance, regeneration, and function | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $3,072,075 | April 1, 2020 | March 31, 2029 | CLEVELAND, DON W | reporter.nih.gov |
| Optimizing a patient-specific regenerative larynx implant for restoration of voice | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $3,070,095 | September 1, 2021 | August 31, 2027 | LOTT, DAVID G | reporter.nih.gov |
| First Aid Medicine to Treat Vesicant Induced Corneal Injury | NIH | National Eye Institute | 2022 to 2025 | $3,055,554 | September 30, 2022 | August 31, 2027 | CHANDLER, HEATHER | reporter.nih.gov |
| Microengineering vascularized and innervated bone-like scaffolds as an alternative to autologous bone grafts | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,048,776 | August 1, 2021 | April 30, 2027 | BERTASSONI, LUIZ EDUARDO | reporter.nih.gov |
| DREAM Complex Maintenance of Human Beta Cell Quiescence | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,048,223 | July 1, 2021 | May 31, 2026 | STEWART, ANDREW F. | reporter.nih.gov |
| Maladaptive Plasticity in Spinal Cord Injury: Cellular Mechanisms | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,042,505 | July 15, 2021 | June 30, 2026 | FERGUSON, ADAM R | reporter.nih.gov |
| Macrophage Depletion Therapy for Spinal Cord Injury | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,042,324 | March 15, 2021 | November 30, 2025 | GENSEL, JOHN C | reporter.nih.gov |
| Retinal Ganglion Cell Replacement in Clinically Relevant Models of Optic Neuropathy | NIH | National Eye Institute | 2021 to 2022 | $3,026,491 | September 30, 2018 | August 31, 2024 | REX, TONIA S | reporter.nih.gov |
| Mitigation of Radiation Induced Gastrointestinal Syndrome. | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,026,290 | August 1, 2023 | July 31, 2026 | NORRIS, ANDREW JOHN | reporter.nih.gov |
| Mitochondrial respiration as a regulator of lymphatic cell fate and therapeutic lymphangiogenesis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,026,108 | July 1, 2022 | June 30, 2027 | OLIVER, GUILLERMO C | reporter.nih.gov |
| Modeling Inner Ear Differentiation with Pluripotent Stem Cells | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $3,024,653 | March 1, 2014 | May 31, 2029 | HASHINO, ERI | reporter.nih.gov |
| Mechanisms and rescue of craniosynostosis associated with gene-environment interaction | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $3,011,888 | July 1, 2021 | April 30, 2027 | CHEN, JIANFU | reporter.nih.gov |
| Commercialization Readiness for Bone Filler Scaffold Device to Aid in Dental Applications and Reconstruction | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $3,006,953 | September 22, 2018 | August 31, 2024 | BALLARD, SHARON C | reporter.nih.gov |
| Generating Exogenic Organs for Transplantation without the Use of Immunosuppression | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,005,890 | September 21, 2022 | July 31, 2027 | STEER, CLIFFORD JOHN | reporter.nih.gov |
| LIVE IMAGING OF BONE REGENERATION IN ZEBRAFISH | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,005,724 | February 1, 2020 | May 31, 2030 | DI TALIA, STEFANO | reporter.nih.gov |
| New BDNF Nanoparticles for Early Treatment of Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2024 | $2,998,661 | September 15, 2017 | August 31, 2025 | VITALIANO, FRANCO | reporter.nih.gov |
| Genetic Regulation of Developmental and Regenerative Growth | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,996,144 | April 1, 2017 | February 28, 2027 | HARIHARAN, ISWAR K. | reporter.nih.gov |
| Development of a novel, regenerative therapy to reverse synapse loss in Alzheimer's Disease | NIH | National Institute on Aging | 2023 to 2024 | $2,994,510 | June 1, 2023 | May 31, 2025 | VANDERKLISH, PETER W | reporter.nih.gov |
| Salivary gland ionocyte organization and function during homeostasis, repair, and disease | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,994,334 | August 18, 2021 | May 31, 2027 | MAKARENKOVA, HELEN P. | reporter.nih.gov |
| Adhesion G Protein-Coupled Receptors in CNS Development and Regeneration | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,987,194 | September 30, 2015 | May 31, 2027 | PIAO, XIANHUA | reporter.nih.gov |
| Stem Cell and Transplantation Biology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,984,057 | August 1, 2015 | July 31, 2028 | STIREWALT, DEREK L | reporter.nih.gov |
| Genetically-engineered stem cells for self-regulating arthritis therapy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,983,611 | April 1, 2022 | March 31, 2027 | GUILAK, FARSHID | reporter.nih.gov |
| Integration and functionality of retinal organoid transplants | NIH | National Eye Institute | 2021 to 2025 | $2,971,351 | May 1, 2021 | March 31, 2027 | SEILER, MAGDALENE J | reporter.nih.gov |
| Programming cellular behavior by mechanical forces | NIH | National Institute of Biomedical Imaging and Bioengineering | 2024 to 2025 | $2,968,476 | September 9, 2024 | August 31, 2029 | BERRO, JULIEN | reporter.nih.gov |
| Photoabsorbing bioinks for expanding 3D printed human liver in situ | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,967,973 | September 21, 2021 | May 31, 2026 | STEVENS, KELLY R | reporter.nih.gov |
| Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Cell Transplant Recipients | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,966,978 | December 1, 2021 | November 30, 2026 | CHENG, GUANG-SHING | reporter.nih.gov |
| MIDAS: MIcroangiopathy, endothelial Damage in Adults undergoing Stem cell transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,957,506 | August 20, 2020 | July 31, 2026 | VASU, SUMITHIRA | reporter.nih.gov |
| Preclinical studies of pluripotent stem cell-derived myogenic progenitors in non-human primates | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,948,443 | August 6, 2021 | December 31, 2026 | PERLINGEIRO, RITA C. R. | reporter.nih.gov |
| Ethanol Effects on the Transcriptional Regulatory Network in Liver Regeneration | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $2,943,903 | September 30, 2009 | July 31, 2027 | SRIVASTAVA, ANKITA | reporter.nih.gov |
| Exosomes and the Immune Response in Allograft Outcomes in Pediatric Transplant Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $2,938,841 | May 10, 2022 | June 30, 2024 | KRAMS, SHERI M. | reporter.nih.gov |
| Single-cell analysis to promote kidney repair | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,938,759 | September 1, 2020 | May 31, 2025 | HUMPHREYS, BENJAMIN D. | reporter.nih.gov |
| A molecular and physical mechanism for growing and branching the intestinal villus | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,934,732 | September 15, 2020 | November 30, 2028 | GARTNER, ZEV JORDAN | reporter.nih.gov |
| Infusible Extracellular Matrix for Treating Myocardial Infarction | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,929,153 | June 10, 2022 | May 31, 2027 | CHRISTMAN, KAREN L | reporter.nih.gov |
| Immunomodulation of juvenile femoral head osteonecrosis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,923,511 | July 1, 2021 | March 31, 2027 | KIM, HARRY K.W. | reporter.nih.gov |
| Mechanistic evaluation of the role of circadian rhythms in acute lung injury and subsequent recovery | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,922,801 | September 20, 2021 | August 31, 2027 | SENGUPTA, SHAON | reporter.nih.gov |
| Specification, Molecular Control and Niche Functions of the Hair Follicle Mesenchyme | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,922,092 | September 15, 2016 | August 31, 2026 | RENDL, MICHAEL | reporter.nih.gov |
| Tissue Engineered Rostral Migratory Stream for Directed Neuronal Replacement | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,919,684 | April 1, 2021 | March 31, 2026 | CULLEN, DANIEL KACY | reporter.nih.gov |
| Systematic Reconstruction of Epithelial-Mesenchymal Communication in Organ Development | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,918,081 | August 15, 2021 | July 31, 2026 | LI, PULIN | reporter.nih.gov |
| Dendrite morphogenesis, function and regeneration | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,908,475 | December 1, 2016 | November 30, 2024 | JAN, YUH NUNG | reporter.nih.gov |
| iPSC-Derived Vascularized Human Lung Organoids and Interaction Between Lung Endothelial Cells and Alveolar Epithelial Cells | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,907,792 | August 1, 2022 | May 31, 2027 | REHMAN, JALEES | reporter.nih.gov |
| Epithelial-Mesenchymal Interactions in Fibrosis Resolution | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,901,344 | August 6, 2009 | April 30, 2027 | TSCHUMPERLIN, DANIEL J. | reporter.nih.gov |
| Protection and restoration of cochlear synapses from noise-induced synaptopathy in male and female mice | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $2,899,116 | June 1, 2021 | May 31, 2027 | GREEN, STEVEN H | reporter.nih.gov |
| Retinal disease models for translational photoreceptor replacement | NIH | National Eye Institute | 2021 to 2022 | $2,898,123 | September 30, 2018 | May 31, 2025 | WOLFE, JOHN H | reporter.nih.gov |
| Preclinical Toxicology Study of Intrathecal VersaMab-101 for spinal cord injury treatment | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $2,885,957 | April 1, 2022 | August 31, 2027 | SUN, MIAO | reporter.nih.gov |
| Using donor dendritic cells to optimize GvHD and GvL in allogeneic stem cell transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,867,908 | June 1, 2020 | May 31, 2026 | WALLER, EDMUND K | reporter.nih.gov |
| WNT1 Function in Stem Cells in Osteogenesis Imperfecta and Craniofacial-Skeletal Tissues | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,862,721 | September 10, 2021 | August 31, 2026 | LEE, BRENDAN | reporter.nih.gov |
| Elucidating the Molecular Mechanisms Underlying LYST-mediated Tissue Engineered Vascular Graft Stenosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,861,908 | April 1, 2021 | March 31, 2026 | BREUER, CHRISTOPHER KANE | reporter.nih.gov |
| Phenotyping Genetic Disorders of Hepatic Lipid and Lipoprotein Metabolism in Cells, Mice, and Men | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,861,646 | January 1, 2017 | December 31, 2024 | GINSBERG, HENRY N | reporter.nih.gov |
| Quantitative Multiparametric MRI to Assess the Effect of Stem Cell Therapy on Chronic Low Back Pain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,858,064 | August 1, 2014 | July 31, 2025 | LI, DEBIAO | reporter.nih.gov |
| Molecular regulation of native hematopoiesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,856,222 | February 15, 2016 | December 31, 2025 | CAMARGO, FERNANDO | reporter.nih.gov |
| Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment Following Hematopoietic Stem Cell Transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,855,157 | May 1, 2020 | April 30, 2026 | KELLER, MICHAEL DANIEL | reporter.nih.gov |
| New upstream targets for HIF-1a-mediated regeneration in young and aged animals | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,854,411 | May 1, 2011 | May 31, 2027 | HEBER-KATZ, ELLEN S. | reporter.nih.gov |
| Wnt signaling in hematopoietic development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,849,578 | January 1, 2017 | June 30, 2025 | WILLERT, KARL H | reporter.nih.gov |
| Beyond the Barrier: Alveolar Epithelial Cell Biology in Health and Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,844,000 | August 15, 2021 | June 30, 2025 | BOROK, ZEA | reporter.nih.gov |
| HEMANGIOBLAST DEVELOPMENT AND REGULATION | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,843,107 | August 1, 1996 | May 31, 2026 | CHOI, KYUNGHEE | reporter.nih.gov |
| Efficacy of a Mindfulness-Based Stress Management Program for Allogeneic HCT Caregivers | NIH | National Cancer Institute | 2021 to 2025 | $2,839,105 | April 1, 2021 | March 31, 2027 | VINCI, CHRISTINE | reporter.nih.gov |
| Decoding LRH-1 Activity in Gut Regeneration and Differentiation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,837,160 | June 14, 2021 | April 30, 2026 | BAYRER, JAMES | reporter.nih.gov |
| Developing gene therapy strategies to treat alpha thalassemia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,821,947 | January 1, 2022 | December 31, 2025 | MACKENZIE, TIPPI | reporter.nih.gov |
| Tailoring of cellular mechanical microenvironments to rescue age-related impairments in bone regeneration | NIH | National Institute on Aging | 2022 to 2025 | $2,821,555 | September 30, 2022 | May 31, 2027 | MORGAN, ELISE F | reporter.nih.gov |
| Developing Cone-Dominant Retinal Disease Models as a Resource for Translational Vision Research | NIH | National Eye Institute | 2021 to 2022 | $2,820,106 | September 30, 2018 | August 31, 2022 | CARROLL, JOSEPH | reporter.nih.gov |
| Genome editing of human pancreatic islets to withstand ischemic injuries and promote immune evasion | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,817,305 | July 1, 2022 | April 30, 2027 | TANG, QIZHI | reporter.nih.gov |
| Myocardial remuscularization by cardiac patch delivery of epicardial FSTL1 and CCND2 overexpressing cardiomyocytes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,816,253 | July 1, 2016 | November 30, 2026 | ZHANG, JIANYI | reporter.nih.gov |
| Mechanisms of HIV-associated epithelialintestinal stem cell (ISC) dysfunction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,811,833 | July 1, 2020 | June 30, 2025 | KWON, DOUGLAS | reporter.nih.gov |
| The role of the intestinal microbiome in cancer immunotherapy | NIH | National Cancer Institute | 2023 to 2025 | $2,811,009 | August 1, 2023 | July 31, 2030 | VAN DEN BRINK, MARCEL R M | reporter.nih.gov |
| Prdm3/16 Regulate Chromatin Accessibility to Determine Alveolar Maturation | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,805,992 | July 1, 2022 | June 30, 2027 | WHITSETT, JEFFREY A | reporter.nih.gov |
| Biomaterials Strategies to Promote Functional Recovery After Ischemic Stroke | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,801,281 | March 1, 2020 | June 30, 2030 | SEGURA, TATIANA | reporter.nih.gov |
| Cellular and molecular analysis of B lymphocyte development and selection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,800,489 | June 15, 2014 | April 30, 2030 | PEREIRA, JOAO | reporter.nih.gov |
| Impact of particle and ozone inhalation co-exposure on alveolar epithelial regeneration | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $2,799,613 | May 1, 2020 | February 28, 2026 | HUSSAIN, SALIK | reporter.nih.gov |
| Neural Circuits, Kinetics and Energetics HTS of Human iPSC-Neurons, -Microglia, and -Astrocytes: AI-Enabled Platform for Target ID, and Drug Discovery and Toxicity (e.g., Cancer Chemo & HIV ARTs) | NIH | National Institute of Mental Health | 2023 to 2025 | $2,798,182 | September 1, 2023 | August 31, 2026 | PRICE, JEFFREY H. | reporter.nih.gov |
| The Role of Renal Interstitium in Kidney Development | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,791,644 | July 15, 2021 | May 31, 2025 | CARROLL, THOMAS JOSEPH | reporter.nih.gov |
| Polymer Scaffolds for Mandibular Condyle Cartilage Regeneration | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $2,788,930 | December 1, 2020 | November 30, 2025 | ALMARZA, ALEJANDRO JOSE | reporter.nih.gov |
| Cardiovascular reserve capacity in survivors of hematopoietic cell transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,785,889 | February 1, 2020 | January 31, 2026 | ARMENIAN, SARO | reporter.nih.gov |
| Bioactive Scaffold for TMJ Disc Regeneration by Endogenous Stem/Progenitor Cells | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $2,782,994 | August 11, 2020 | July 31, 2026 | LEE, CHANG HUN | reporter.nih.gov |
| Targeting vascular dysfunction to promote lung repair and fibrosis resolution | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,782,716 | March 5, 2022 | February 28, 2027 | LIGRESTI, GIOVANNI | reporter.nih.gov |
| Vascularized Islet transplantation NICHE with local immunosuppression for the treatment of type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,778,087 | July 1, 2022 | April 30, 2027 | GRATTONI, ALESSANDRO | reporter.nih.gov |
| Intraosseous delivery of lentiviral vectors for hemophilia A gene therapy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,777,901 | August 15, 2016 | June 30, 2026 | MIAO, CAROL H | reporter.nih.gov |
| Mechanisms and Impact of Pregnancy-Induced Adaptations in Pelvic Floor Muscles | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,761,892 | August 1, 2017 | June 30, 2026 | ALPERIN, MARIANNA | reporter.nih.gov |
| Defining mechanisms of aortic root aneurysm in Loeys-Dietz syndrome using patients’ induced pluripotent stem cells and genome editing | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,760,413 | May 1, 2020 | April 30, 2026 | YANG, BO | reporter.nih.gov |
| Computational and Experimental Modeling of Cardiomyocyte Proliferation | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,757,722 | January 1, 2022 | December 31, 2026 | SAUCERMAN, JEFFREY J. | reporter.nih.gov |
| Functional Biointegration of Bioengineered Salivary Tissues in Irradiated Animal Models | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $2,754,807 | September 19, 2022 | June 30, 2027 | FARACH-CARSON, MARY C | reporter.nih.gov |
| Image-guided combination therapies for radiotherapy-induced neurocognitive impairment in pediatric brain tumor survivors | NIH | National Cancer Institute | 2021 to 2025 | $2,750,972 | July 12, 2021 | June 30, 2027 | NGEN, ETHEL JOSO | reporter.nih.gov |
| In vivo HSC gene therapy using a multi-modular HDAd vector for HIV cure | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,743,808 | January 10, 2023 | December 31, 2027 | LIEBER, ANDRE MICHAEL | reporter.nih.gov |
| Cadherin-Dependent Regulation of Satellite Cell Function | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,741,976 | July 15, 2016 | June 30, 2027 | KRAUSS, ROBERT S. | reporter.nih.gov |
| Determining how chronic ETOH influences the regenerative activities of hepatocyte subpopulations | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $2,741,497 | August 1, 2021 | April 30, 2026 | ZHU, HAO | reporter.nih.gov |
| Protection of Ischemic Myocardium | NIH | National Heart, Lung, and Blood Institute | 2021 | $2,741,275 | December 1, 2004 | August 31, 2023 | BOLLI, ROBERTO | reporter.nih.gov |
| Neural activity-dependent modulation of cortical microvascular restoration | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,739,026 | March 15, 2021 | December 31, 2025 | XU, XIANGMIN | reporter.nih.gov |
| Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,737,027 | May 1, 2012 | March 31, 2027 | WU, JOSEPH C. | reporter.nih.gov |
| Angiogenic and anti-microbial supports for pulp regeneration | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $2,731,189 | February 23, 2022 | August 15, 2025 | KUMAR, VIVEK | reporter.nih.gov |
| Conformal Total Body and Marrow Irradiation for Leukemia | NIH | National Cancer Institute | 2021 to 2024 | $2,727,228 | September 13, 2011 | December 31, 2025 | HUI, SUSANTA K | reporter.nih.gov |
| In Vitro Human Tissue-Engineered Blood Vessel Disease Model of Progeria | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,720,700 | August 1, 2017 | April 30, 2027 | TRUSKEY, GEORGE A | reporter.nih.gov |
| Systems Genetics of Bone Regeneration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,717,663 | April 15, 2022 | January 31, 2027 | FARBER, CHARLES R | reporter.nih.gov |
| Neutralizing the degenerate disc microenvironment to enhance the efficacy of therapeutic stem cells | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,717,504 | February 1, 2021 | December 31, 2026 | SMITH, LACHLAN JAMES | reporter.nih.gov |
| New roles of endothelial regrowth in ischemic tissue recovery and regeneration | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,697,119 | April 1, 2022 | March 31, 2027 | KUME, TSUTOMU | reporter.nih.gov |
| Epigenetic Profiling of circulating cell-free DNA for the Monitoring of Graft-Versus-Host Disease after Hematopoietic Cell Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,694,538 | January 13, 2020 | December 31, 2025 | DE VLAMINCK, IWIJN | reporter.nih.gov |
| Emergency Myelopoiesis in the Pathogenesis of Myeloid Malignancies | NIH | National Cancer Institute | 2021 to 2025 | $2,690,224 | August 1, 2021 | July 31, 2027 | PASSEGUE, EMMANUELLE | reporter.nih.gov |
| Clinical Significance of MHC Haplotypes in HCT | NIH | National Cancer Institute | 2021 to 2025 | $2,687,420 | March 1, 2003 | August 31, 2028 | PETERSDORF, EFFIE W | reporter.nih.gov |
| Enhancing Innate Immune Reconstitution Post Allogeneic HSCT. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,685,463 | September 1, 2021 | June 30, 2025 | SERODY, JONATHAN S. | reporter.nih.gov |
| Implementation of an interventional, risk-adapted clinical trial for children with newly diagnosed juvenile myelomonocytic leukemia. | NIH | National Cancer Institute | 2022 to 2025 | $2,677,641 | August 1, 2022 | July 31, 2027 | STIEGLITZ, ELLIOT | reporter.nih.gov |
| Metabolic Control of Stemness in lung epithelial progenitors by FAM13A | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,676,003 | April 1, 2015 | November 30, 2025 | ZHOU, ANNY XIAOBO | reporter.nih.gov |
| Study of Activity-Dependent Sympathetic Sprouting | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,675,718 | May 4, 2004 | June 30, 2026 | ZHANG, JUN-MING | reporter.nih.gov |
| Cardiomyocyte Non-autonomous Factors and Cardiac Regeneration in Large Mammals | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,675,195 | August 9, 2022 | June 30, 2027 | ZHU, WUQIANG | reporter.nih.gov |
| Immuno-Isolating capsule for delivery of cell-based therapy for restoration of ovarian endocrine function in an animal model | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,674,237 | August 15, 2022 | May 31, 2027 | SHIKANOV, ARIELLA | reporter.nih.gov |
| Corneal Epithelial-Stromal Interactions During Regeneration and Fibrosis | NIH | National Eye Institute | 2021 to 2025 | $2,667,355 | December 1, 1984 | August 31, 2027 | CIOLINO, JOSEPH B. | reporter.nih.gov |
| Rehabilitation from Spinal Cord Injury Using Targeted, Activity-Dependent Intraspinal Stimulation | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,662,265 | August 15, 2021 | July 31, 2026 | PERLMUTTER, STEVE I | reporter.nih.gov |
| Ceramide-Induced Destruction in Emphysema | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,661,589 | July 1, 2006 | April 30, 2025 | PETRACHE, IRINA | reporter.nih.gov |
| Negative regulators of endothelial regeneration in aging lungs and ARDS | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,661,375 | June 1, 2022 | March 31, 2026 | ZHAO, YOU-YANG | reporter.nih.gov |
| Targeted Degradation of Extracellular Proteins to Enhance Brain Plasticity | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $2,660,000 | September 12, 2024 | August 31, 2029 | ALLEN, NICOLA J | reporter.nih.gov |
| Epigenetic Regulation of Skin Regional Specificity | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,657,118 | May 1, 2002 | March 31, 2028 | CHUONG, CHENG-MING | reporter.nih.gov |
| Antimicrobial dermal matrices to promote infection free wound closure in DTU-DFUs. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $2,649,424 | September 1, 2023 | August 31, 2025 | MEHTA, MANAV | reporter.nih.gov |
| Regulation of Skeletal progenitor cells in Osteogenesis Imperfecta | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $2,636,174 | July 13, 2022 | April 30, 2027 | PARK, DONGSU | reporter.nih.gov |
| Stress and Human Stem/Progenitor Cells: Biobehavioral Mechanisms | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,635,227 | August 15, 2022 | June 30, 2027 | WADHWA, PATHIK D | reporter.nih.gov |
| Augmenting Implanted Neuroprosthetics with Targeted Health Monitoring for Spinal Cord Injury - the LIFELINE | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2024 | $2,632,178 | July 1, 2021 | March 31, 2026 | KILGORE, KEVIN L. | reporter.nih.gov |
| Psychosocial Stress Effects on Regenerative Medicine Therapies for Lower Urinary Tract Disorders in Nonhuman Primates | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,630,241 | April 1, 2020 | March 31, 2026 | SHIVELY, CAROL A. | reporter.nih.gov |
| Clinically Applicable Orofacial Cleft Reconstruction Using Structural, Compositional Biomimetic Bone Scaffolds | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $2,621,884 | August 1, 2022 | July 31, 2027 | LEE, SANG JIN | reporter.nih.gov |
| Defining Characteristics of Cortical Progenitor Cells over Time in Mouse and Human | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,620,540 | December 15, 2016 | November 30, 2025 | TEMPLE, SALLY | reporter.nih.gov |
| Biomechanical Forces and the Enteric Nervous System: Advancing the Development and Function of Tissue-Engineered Intestine | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,618,975 | September 8, 2025 | September 7, 2029 | SPEER, ALLISON LEIGH | reporter.nih.gov |
| In Vivo Hematopoietic Stem Cell Gene Therapy of Beta-Thalassemia and Sickle Cell Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,618,613 | June 1, 2016 | July 31, 2025 | LIEBER, ANDRE MICHAEL | reporter.nih.gov |
| Bioresorbable Zinc Staples for Anastomoses in the Digestive Tract | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,616,912 | February 3, 2022 | January 31, 2027 | ZHU, DONGHUI | reporter.nih.gov |
| Regenerative pathways in the avian cochlea | NIH | National Institute on Deafness and Other Communication Disorders | 2022 to 2025 | $2,615,111 | February 10, 2022 | January 31, 2027 | HELLER, STEFAN | reporter.nih.gov |
| Synthetic gene sensors and effectors to redirect organoid development | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2024 | $2,608,452 | May 1, 2021 | July 31, 2025 | WEISS, RON | reporter.nih.gov |
| Development of 211Astatine-Conjugated Anti-CD45 Antibody-Based Conditioning for Hematopoietic Stem Cell Gene Therapy and Editing | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,608,434 | May 15, 2020 | April 30, 2026 | WALTER, ROLAND BRUNO | reporter.nih.gov |
| Translational Nonhuman Primate Regenerative Medicine and Gene Therapy/Genome Editing Resource Program | NIH | Office of the Director, National Institutes of Health | 2023 to 2025 | $2,607,543 | December 1, 2022 | November 30, 2026 | TARANTAL, ALICE F | reporter.nih.gov |
| Intravital analysis of hematopoietic stem cells in their bone marrow niche - Resubmission - 1 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,607,213 | September 20, 2021 | August 31, 2025 | REIZIS, BORIS | reporter.nih.gov |
| Transcriptional networks establishing the precise gene expression states that define neurosensory cell identity in the inner ear | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $2,603,881 | February 1, 2016 | June 30, 2027 | XU, PIN-XIAN | reporter.nih.gov |
| NATIONAL BIOREPOSITORY OF LUNG DISEASE-SPECIFIC HUMAN INDUCED PLURIPOTENT STEM CELLS:THE PURPOSE OF THIS RESOURCE IS TO BUILD AND SUPPORT A CRITICAL | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,600,000 | May 1, 2020 | April 30, 2025 | N/A, N/A | reporter.nih.gov |
| Genetic Regulatory Network in Craniofacial Development | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,599,984 | March 12, 2025 | January 31, 2030 | HSU, WEI | reporter.nih.gov |
| The Neurospan Bridge: A Device for Peripheral Nerve Repair | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $2,594,464 | March 15, 2023 | August 31, 2027 | KOFFLER, YACOV | reporter.nih.gov |
| Macrophage Phenotypes and Tissue Repair | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,593,825 | May 1, 2020 | March 31, 2030 | KOH, TIMOTHY J | reporter.nih.gov |
| Suturable bioprinted vascularized muscle constructs for treatment of skeletal muscle loss | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,591,324 | March 1, 2021 | February 28, 2027 | SHIN, SU RYON | reporter.nih.gov |
| ETS-family Transcription Factor Mediated Control of Pulmonary Inflammation Induced by Influenza Viruses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,590,407 | February 1, 2019 | October 31, 2028 | HEATON, NICHOLAS S | reporter.nih.gov |
| Tissue Patterning in living skin and organ explants | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,589,841 | September 1, 2025 | August 31, 2030 | CHUONG, CHENG-MING | reporter.nih.gov |
| An Interneuron-based Cell Therapy for Epilepsy | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,589,602 | September 1, 2010 | March 31, 2027 | BARABAN, SCOTT C | reporter.nih.gov |
| Understanding and Controlling Macrophage Behavior in Angiogenesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,588,824 | January 1, 2016 | August 31, 2025 | SPILLER, KARA LORRAINE | reporter.nih.gov |
| Development of a stem-cell derived thymic cell therapy to treat patients with athymia | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,586,728 | April 15, 2022 | January 31, 2027 | LIM, BING | reporter.nih.gov |
| Heterogeneity of Satellite Cell Populations Play a Role in Improvements in PAD after Exercise Therapy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,586,669 | February 15, 2022 | January 31, 2027 | HANSEN, LAURA MARIE | reporter.nih.gov |
| Synthetic organogenesis: new paradigms in reconstituting human organ development in vitro | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,586,456 | September 21, 2021 | August 31, 2026 | SIMUNOVIC, MIJO | reporter.nih.gov |
| Elucidating electrical stimulation induced non-neuronal activity using emerging in vivo imaging technology and electrophysiology | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,585,973 | September 30, 2020 | June 30, 2025 | KOZAI, TAKASHI DANIEL YOSHIDA | reporter.nih.gov |
| Rectifying splicing mutations in blood disorders by gene editing | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,584,045 | December 20, 2019 | November 30, 2023 | BAUER, DANIEL EVAN | reporter.nih.gov |
| Microribbon scaffold-mediated Immunomodulation for Cranial Bone Repair | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,582,020 | January 1, 2015 | May 31, 2027 | YANG, FAN | reporter.nih.gov |
| Leveraging immune-fibroblast interactions for biomaterial induced skin regeneration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,580,501 | September 1, 2021 | August 31, 2027 | SCUMPIA, PHILIP | reporter.nih.gov |
| Targeted genetic engineering of B cells to induce protective antibody responses to viral pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $2,577,835 | July 5, 2022 | June 30, 2027 | ADAIR, JENNIFER EILEEN | reporter.nih.gov |
| COATs: Collagen-mimetic peptide and therapeutic gene-modified collagens for cell-mediated healing of diabetic foot ulcers | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,574,620 | July 30, 2021 | May 31, 2027 | SULLIVAN, MILLICENT O | reporter.nih.gov |
| Regeneration of the Immune System after Radiation Exposure | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,571,006 | August 18, 2022 | June 30, 2027 | GUHA, CHANDAN | reporter.nih.gov |
| Regulation of catagen regression and progenitor pruning by the dermal sheath | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,565,274 | July 1, 2021 | June 30, 2026 | RENDL, MICHAEL | reporter.nih.gov |
| Bioinspired Mechanically Stiff Hydrogels for Osteochondral Tissue Regeneration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,563,338 | July 25, 2016 | March 31, 2027 | BRYANT, STEPHANIE J | reporter.nih.gov |
| The Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,563,053 | August 1, 2020 | July 31, 2025 | HUARD, JOHNNY | reporter.nih.gov |
| Mechanisms for Regenerative Healing in Intervertebral Discs | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,560,545 | January 15, 2022 | December 31, 2026 | IATRIDIS, JAMES C. | reporter.nih.gov |
| Using 3D Nonwovens Fabrication to Engineer Region-Specific Extracellular Matrix Structure and Bioactivity of the Knee Meniscus | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,558,913 | July 1, 2021 | June 30, 2027 | FISHER, MATTHEW B | reporter.nih.gov |
| Vascular networks genetically engineered for protein drug delivery | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,552,882 | August 15, 2015 | April 30, 2026 | MELERO-MARTIN, JUAN M | reporter.nih.gov |
| Manipulation of Host Tissue to Induce a Hierarchical Microvasculature | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,550,390 | May 1, 2023 | April 30, 2027 | SHEIKHI, AMIR | reporter.nih.gov |
| A first in human clinical study of TT101, a synthetic immunomodulatory material to build new functional tissue over exposed bone as a one time treatment for diabetic limb preservation patients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $2,549,496 | September 15, 2021 | August 31, 2024 | DESHAYES, STEPHANIE | reporter.nih.gov |
| Phase1/2a Clinical Trial of RPESC-derived RPE Transplantation as Therapy for Non-exudative Age-related Macular Degeneration | NIH | National Eye Institute | 2021 to 2024 | $2,549,156 | September 30, 2020 | September 29, 2025 | STERN, JEFFREY H | reporter.nih.gov |
| Roles of Noncoding RNA in Bone Regeneration | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $2,547,514 | March 1, 2016 | August 31, 2025 | CHEN, JAKE JINKUN | reporter.nih.gov |
| The Molecular Regulation of Horizontal Basal Cell Activation in the Olfactory Epithelium | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2024 | $2,546,159 | February 7, 2020 | January 31, 2026 | SCHWOB, JAMES E. | reporter.nih.gov |
| Engineering Adaptive Immune Responses from Hydrogel Scaffolds to Promote Tissue Regeneration | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,544,732 | March 2, 2020 | February 28, 2026 | SEGURA, TATIANA | reporter.nih.gov |
| Intestinal tissue intrinsic mechanisms in regulation of GI GVHD | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,544,373 | June 13, 2022 | May 31, 2027 | REDDY, PAVAN | reporter.nih.gov |
| Harnessing Neuroplasticity of Postural Sensorimotor Networks Using Non-Invasive Spinal Neuromodulation to Maximize Functional Recovery After Spinal Cord Injury | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,544,362 | December 1, 2021 | August 31, 2027 | SAYENKO, DIMITRY | reporter.nih.gov |
| Hair Follicle Dermal Stem Cell Functions and Potential | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,543,600 | July 8, 2021 | June 30, 2026 | RENDL, MICHAEL | reporter.nih.gov |
| Functional roles of lymphatics in organogenesis and tissue repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,543,362 | January 7, 2021 | December 31, 2025 | OLIVER, GUILLERMO C | reporter.nih.gov |
| Mechanisms of Hematopoietic Stem Cell and Blood aging | NIH | National Institute on Aging | 2021 to 2025 | $2,543,077 | September 15, 2021 | May 31, 2027 | PASSEGUE, EMMANUELLE | reporter.nih.gov |
| The Role of Ceramides in the Intestinal Stem Cell | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,539,916 | September 23, 2021 | May 31, 2026 | SUMMERS, SCOTT A | reporter.nih.gov |
| Prevention of pelvic floor muscle dysfunction with extracellular matrix hydrogel | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,535,698 | September 30, 2020 | June 30, 2026 | ALPERIN, MARIANNA | reporter.nih.gov |
| Genetic interactions and multifactorial genetics mediate myocardial regeneration | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,532,602 | February 11, 2021 | June 30, 2026 | PATTERSON, MICHAELA | reporter.nih.gov |
| Randomized study of low versus moderate dose busulfan in transplant for severe combined immunodeficiency | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,529,105 | August 24, 2017 | July 31, 2024 | WAYNE, ALAN S. | reporter.nih.gov |
| Improving transfusion therapy for patients with sickle cell disease with pluripotent stem cell-derived red cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,528,360 | September 15, 2016 | May 31, 2025 | CHOU, STELLA T | reporter.nih.gov |
| Life history of the menstruating uterus | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,527,271 | September 20, 2022 | August 31, 2027 | MCKINLEY, KARA LAVIDGE | reporter.nih.gov |
| Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,527,128 | September 20, 2016 | May 31, 2025 | SNOECK, HANS-WILLEM E | reporter.nih.gov |
| Flexor tendon intrinsic healing and intervention strategy development | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,522,341 | July 1, 2021 | June 30, 2027 | ZHAO, CHUNFENG | reporter.nih.gov |
| Pro-youthful role of Gpld1 on regenerative and cognitive function in the aged brain | NIH | National Institute on Aging | 2022 to 2025 | $2,521,023 | May 15, 2022 | April 30, 2027 | VILLEDA, SAUL A | reporter.nih.gov |
| Metabolomics Technologies to Advance Biomedical Research | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,516,384 | March 1, 2019 | March 31, 2029 | SIUZDAK, GARY E | reporter.nih.gov |
| Dysfunctional skeletal muscle communication in arsenic-promoted cardiometabolic disease | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $2,513,851 | July 23, 2021 | June 30, 2026 | BARCHOWSKY, AARON | reporter.nih.gov |
| In vivo modelling and therapy development for stathmin-2 loss in TDP-43 proteinopathies | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $2,507,311 | August 1, 2021 | July 31, 2024 | LAGIER-TOURENNE, CLOTILDE | reporter.nih.gov |
| Editing Alveolar Progenitor Cells for Correction of Monogenic Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,504,499 | September 23, 2016 | May 31, 2025 | WHITSETT, JEFFREY A | reporter.nih.gov |
| Role of Fbxw7-Mediated Proteasomal Degradation in Myofibers in Determining Muscle Stem Cell Pool Size | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,494,858 | July 1, 2020 | December 31, 2026 | SACCO, ALESSANDRA | reporter.nih.gov |
| Defining the role of lymphatic vessels in wound healing | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,493,383 | April 1, 2021 | March 31, 2027 | HORSLEY, VALERIE | reporter.nih.gov |
| The role of PHF6 in the control of hematopoietic stem cell aging. | NIH | National Institute on Aging | 2021 to 2025 | $2,490,000 | September 1, 2021 | May 31, 2027 | PALOMERO, TERESA | reporter.nih.gov |
| MG53 function in muscle aging | NIH | National Institute on Aging | 2022 to 2025 | $2,487,828 | September 30, 2022 | June 30, 2027 | MA, JIANJIE | reporter.nih.gov |
| Using a SMART Design to Optimize PTSD Symptom Management Strategies Among Cancer Survivors | NIH | National Cancer Institute | 2021 to 2024 | $2,482,100 | December 1, 2019 | November 30, 2025 | SMITH, SOPHIA K. | reporter.nih.gov |
| Genetic dissection of trait variation between long-diverged mouse species | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $2,481,029 | September 30, 2019 | June 30, 2025 | BREM, RACHEL BETH | reporter.nih.gov |
| Osteoimmunology of Retarded Bone Regeneration in Periodontitis | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,478,353 | December 1, 2024 | July 31, 2026 | KAWAI, TOSHIHISA | reporter.nih.gov |
| Trimodal Vitality Imaging of Neural Progenitor Cells in the Spinal Cord | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,476,665 | August 1, 2020 | April 30, 2027 | EMELIANOV, STANISLAV Y | reporter.nih.gov |
| Multimodality Intervention to Improve Function and Metabolism in Spinal Cord Injury | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $2,474,995 | August 21, 2018 | April 30, 2024 | BHASIN, SHALENDER | reporter.nih.gov |
| Bioprintable composite materials and microfluidic tools for vocal fold restoration and repair | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $2,474,309 | January 1, 2021 | December 31, 2026 | MONGEAU, LUC | reporter.nih.gov |
| Neurotrophins and post-infarct plasticity in cardiac sympathetic neurons | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,471,774 | July 15, 2009 | June 30, 2028 | HABECKER, BETH A | reporter.nih.gov |
| Determination of Hair Cell Fate from Postnatal Cochlear Supporting Cells | NIH | National Institute on Deafness and Other Communication Disorders | 2022 to 2025 | $2,469,452 | May 4, 2022 | April 30, 2027 | EDGE, ALBERT | reporter.nih.gov |
| Lung leukocytes promote alveolar epithelial regeneration after severe injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,469,157 | May 1, 2020 | April 30, 2026 | ARPAIA, NICHOLAS | reporter.nih.gov |
| Hormetic ER Stress Regulation of Hematopoietic Stem Cell Function | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,466,695 | July 3, 2021 | May 31, 2026 | LUCHSINGER, LARRY L | reporter.nih.gov |
| Regulation of endothelial cell specification | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,466,084 | February 15, 2021 | January 31, 2025 | PU, WILLIAM TSWENCHING | reporter.nih.gov |
| Engineered Granular Hydrogels for Endogenous Tissue Repair | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,464,894 | May 26, 2022 | April 30, 2027 | BURDICK, JASON A | reporter.nih.gov |
| A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,464,828 | September 24, 2020 | August 31, 2025 | HUGHES, MOLLY A | reporter.nih.gov |
| Mechanism of transplanted neonatal cardiac progenitor cells to repair ischemic myocardium | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,462,741 | April 20, 2014 | August 31, 2025 | SCHUMACKER, PAUL T | reporter.nih.gov |
| Deciphering multi-scale differentiation and patterning cues driving whole craniofacial joint regeneration | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $2,462,001 | September 6, 2022 | August 31, 2027 | SMEETON, JOANNA MARJORIE | reporter.nih.gov |
| Brain lymphatic activation for craniosynostosis and Alzheimer’s disease | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $2,461,369 | June 1, 2024 | May 31, 2027 | CHEN, JIANFU | reporter.nih.gov |
| Identifying pathways required for integration of kidney organoid and host epithelia | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,461,009 | September 1, 2020 | May 31, 2025 | DRUMMOND, IAIN A. | reporter.nih.gov |
| An integrated human stem cell model for elucidating myocardial-endocardial interactions in cardiac development and disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,460,707 | February 15, 2021 | January 31, 2027 | ZHAO, MINGTAO | reporter.nih.gov |
| Angiogenic Therapy: Novel Approaches to Enhance Bone Regeneration in Aging - AD/ADRD | NIH | National Institute on Aging | 2021 to 2023 | $2,458,774 | April 1, 2019 | January 31, 2025 | KACENA, MELISSA A | reporter.nih.gov |
| Alveolar epithelial stress-induced polyploidization in lung injury and repair | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,458,344 | May 15, 2022 | April 30, 2027 | GOTTARDI, CARA J | reporter.nih.gov |
| Respiratory interneuron circuit plasticity: promoting recovery of diaphragm function after spinal cord injury | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,455,409 | March 1, 2013 | April 30, 2028 | LEPORE, ANGELO C. | reporter.nih.gov |
| Characterization of Neural Stem Cells in Adult Brain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,454,507 | April 1, 1990 | March 31, 2026 | ALVAREZ-BUYLLA, ARTURO | reporter.nih.gov |
| Pathogenesis of Airway Stem Cell Abnormalities in Obliterative Bronchiolitis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,452,366 | April 1, 2019 | January 31, 2029 | PAREKH, KALPAJ RAJNIKANT | reporter.nih.gov |
| Regenerative Rehabilitation of Complex Musculoskeletal Injuries | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,452,287 | April 1, 2016 | December 31, 2026 | GULDBERG, ROBERT E | reporter.nih.gov |
| Biochemistry of Leukemia Virus Core-Binding Factor | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,451,198 | August 10, 1993 | June 30, 2025 | SPECK, NANCY | reporter.nih.gov |
| Emergency Myelopoiesis Pathways in the Control of Blood Production | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,450,418 | April 1, 2017 | March 31, 2025 | PASSEGUE, EMMANUELLE | reporter.nih.gov |
| Adenylate Kinase 2 Deficiency and the Failure of Myelopoiesis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,449,815 | April 1, 2022 | March 31, 2027 | WEINACHT, KATJA GABRIELE | reporter.nih.gov |
| Control of GVHD by Probiotics with individual Commensal Bacteria | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,448,717 | May 5, 2022 | April 30, 2027 | YU, XUE-ZHONG | reporter.nih.gov |
| Metabolic reprogramming of Alveolar Type 2 cells in response to lung injury | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,446,943 | July 1, 2022 | September 30, 2026 | GUTTENTAG, SUSAN H. | reporter.nih.gov |
| A novel bioengineering approach to restoring permanent periodontal inflammatory bone loss | NIH | National Institute of Dental & Craniofacial Research | 2023 to 2025 | $2,446,598 | July 1, 2023 | April 30, 2028 | JANG, HAE LIN | reporter.nih.gov |
| REGULATION OF ATROPHY-INDUCED PROGENITOR CELLS IN THE GASTRIC CORPUS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,446,210 | September 11, 2012 | April 30, 2028 | MILLS, JASON C | reporter.nih.gov |
| Tomotherapy and Hematopoietic Stem Cells for Tolerance to Kidney Transplants | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $2,439,463 | August 1, 2012 | April 30, 2024 | KAUFMAN, DIXON B | reporter.nih.gov |
| Machine learning with immunogenetics for the prediction of hematopoietic cell transplant outcomes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,438,515 | January 5, 2021 | December 31, 2025 | HSU, KATHARINE C | reporter.nih.gov |
| Genomic tools for massively parallel recording of signaling activity at cellular resolution in a brain-wide manner | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,437,500 | September 22, 2022 | August 31, 2027 | RAJ, BUSHRA | reporter.nih.gov |
| BMP2 Regulation of Periosteal Function | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,436,018 | August 1, 2020 | April 30, 2026 | ROSEN, VICKI | reporter.nih.gov |
| Mechanisms that regulate erythroid differentiation of hematopoietic stem cells | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,434,029 | July 1, 2022 | June 30, 2027 | NAKADA, DAISUKE | reporter.nih.gov |
| Stem cells for therapeutics discovery in genetic blood disorders | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,429,809 | September 23, 2016 | May 31, 2025 | DALEY, GEORGE Q | reporter.nih.gov |
| Engineering islet-like organoids from gastric stem cells for T1D cell replacement therapy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,428,878 | September 12, 2022 | May 31, 2026 | RAFII, SHAHIN | reporter.nih.gov |
| In vivo Monitoring of Neutrophil Function in Patients after Stem Cell Transplant | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,426,537 | February 13, 2023 | January 31, 2028 | IRIMIA, DANIEL | reporter.nih.gov |
| Allorecognition, parasitic stem cells and regeneration in a basal chordate | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,424,717 | January 1, 2021 | December 31, 2026 | DE TOMASO, ANTHONY W | reporter.nih.gov |
| Photoresponsive materials to study matricellular signaling dynamics during crypt formation and fission | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,423,541 | August 1, 2019 | April 30, 2028 | ANSETH, KRISTI S. | reporter.nih.gov |
| Elucidating spinal sensorimotor network components that underlie recovery of motor functions via lumbosacral epidural electrical stimulation in humans with spinal cord injury | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,420,406 | August 15, 2020 | July 31, 2025 | GRAHN, PETER JONAS | reporter.nih.gov |
| Modulation of signaling from damage-associated molecular patterns to improve radiation-induced thymic dysfunction | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,418,442 | July 18, 2022 | May 31, 2027 | DUDAKOV, JARROD | reporter.nih.gov |
| The role of mitochondria in hematopoietic stem cell self-renewal | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,417,109 | January 1, 2021 | December 31, 2024 | FILIPPI, MARIE-DOMINIQUE | reporter.nih.gov |
| High resolution transcriptome and gene regulatory mapping of human ureter and bladder across the lifespan | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,415,000 | September 30, 2021 | July 31, 2027 | WESSELY, OLIVER | reporter.nih.gov |
| Mathematical ecology models of host-microbiota interaction in auto microbiota transplants (auto-FMT) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,414,163 | February 1, 2019 | January 31, 2024 | XAVIER, JOAO | reporter.nih.gov |
| Genetic circuitry governing heart growth and repair | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,413,285 | March 1, 2022 | February 28, 2027 | HUANG, GUO | reporter.nih.gov |
| Immunoevasive Engineered Living Blood Vessels | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $2,412,484 | August 5, 2022 | April 30, 2027 | CHAIKOF, ELLIOT | reporter.nih.gov |
| Innate immune response signaling in cardiac injury healing | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,408,533 | January 1, 2022 | December 31, 2026 | MOLKENTIN, JEFFERY D | reporter.nih.gov |
| Basal cells in airway and alveolar remodeling | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,407,737 | May 1, 2022 | April 30, 2026 | STRIPP, BARRY R | reporter.nih.gov |
| SMART BIOELECTRONIC IMPLANTS FOR CONTROLLED DELIVERY OF THERAPEUTIC PROTEINS IN VIVO AND ITS APPLICATION IN LONG-TERM TREATMENT OF HEMOPHILIA A | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $2,406,599 | May 1, 2022 | January 31, 2026 | ANDERSON, DANIEL G | reporter.nih.gov |
| Next generation anti-cancer drugdelivering cement for bone metastasis patients | NIH | National Cancer Institute | 2022 to 2025 | $2,399,999 | September 1, 2022 | August 31, 2027 | JANG, HAE LIN | reporter.nih.gov |
| Continuation of The Collaborative Islet Transplantation Registry (CITR) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,399,074 | September 15, 2022 | June 30, 2027 | PAYNE, ELIZABETH HOLLY | reporter.nih.gov |
| Optimizing Surgical Transplant of CFTR Gene-Corrected Human Basal Stem Cells to the Upper Airway | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,392,495 | March 1, 2021 | January 31, 2027 | NAYAK, JAYAKAR V | reporter.nih.gov |
| Promoting T cell reconstitution after hematopoietic cell transplantation | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,391,092 | January 1, 2024 | December 31, 2030 | DUDAKOV, JARROD | reporter.nih.gov |
| Scalable and transplantable pancreatic islet organoids with engineered oxygenation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,390,830 | September 1, 2025 | August 31, 2029 | KOMATSU, HIROTAKE | reporter.nih.gov |
| HIV Reservoir and Gene Modified Cell Dynamics Following Autologous Stem Cell Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,390,244 | January 13, 2023 | December 31, 2026 | HENRICH, TIMOTHY JENSEN | reporter.nih.gov |
| Epithelial stem/progenitor cells as repair agents in diffuse alveolar damage | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,388,592 | September 21, 2016 | May 31, 2025 | CHAPMAN, HAROLD A | reporter.nih.gov |
| Development of a Microphysiological Organ-on-Chip System to Model Amyotrophic | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $2,385,538 | September 15, 2017 | February 28, 2024 | SVENDSEN, CLIVE NIELS | reporter.nih.gov |
| Regulation of Ribosome Biogenesis in Hematopoietic Stem Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,385,337 | September 18, 2020 | August 31, 2025 | TONG, WEI | reporter.nih.gov |
| Endothelial plasticity in cardiac repair after myocardial infarction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,384,851 | August 11, 2021 | July 31, 2025 | FAN, YI | reporter.nih.gov |
| Mechanisms of Neural Stem Cell Mechanoregulation | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,383,261 | May 1, 2012 | April 30, 2027 | SCHAFFER, DAVID V | reporter.nih.gov |
| CRISPR-induced cardiovascular progenitor cells to repair myocardial infarction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,382,655 | April 1, 2021 | March 31, 2026 | WANG, YIGANG | reporter.nih.gov |
| From intra to intercellular regulatory networks that define cell type identity | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,381,600 | August 1, 2017 | July 31, 2027 | CAHAN, PATRICK | reporter.nih.gov |
| Toxicology and Efficacy Studies of Intrathecal VersaMab-101 for spinal cord injury treatment | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $2,380,552 | September 18, 2023 | August 31, 2026 | SUN, MIAO | reporter.nih.gov |
| The 4D nucleome of muscle regeneration in ischemia-induced tissue damage and repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,377,116 | September 20, 2020 | August 31, 2025 | DIAO, YARUI | reporter.nih.gov |
| Cxcl12-Hedgehog signaling in cranial bone regeneration | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $2,375,113 | July 5, 2016 | June 30, 2027 | YANG, YINGZI | reporter.nih.gov |
| Improve Lung Regeneration Through Targeting Tuft Cells Following Viral Infection | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,371,262 | August 20, 2021 | June 30, 2026 | QUE, JIANWEN | reporter.nih.gov |
| Developing Human Pluripotent Stem Cell Tools for Region-Specific Pain Circuits | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $2,370,000 | September 6, 2024 | August 31, 2027 | IYER, NISHA | reporter.nih.gov |
| Regulation and manipulation of the telomerase RNA component in hematopoiesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,367,468 | December 1, 2015 | May 14, 2026 | AGARWAL, SUNEET | reporter.nih.gov |
| Uncovering molecular effectors of mammalian aging | NIH | National Institute on Aging | 2021 to 2022 | $2,366,000 | September 30, 2018 | May 19, 2025 | WAGERS, AMY JO | reporter.nih.gov |
| Mechanotransduction and transcriptional regulation during artery development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,363,601 | September 1, 2015 | June 30, 2025 | RED-HORSE, MARY | reporter.nih.gov |
| Trillion cell culture to fuel organ biofabrication | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,361,000 | September 1, 2022 | August 31, 2027 | SKYLAR-SCOTT, MARK A. | reporter.nih.gov |
| Therapeutic ECM Resorption in Cellular Systems and Precision Cut Lung Slices. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,360,154 | December 15, 2020 | November 30, 2025 | TSCHUMPERLIN, DANIEL J. | reporter.nih.gov |
| CGT and ACD Inhibitors for SRT Treatment of Krabbe Disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,357,715 | September 22, 2022 | August 31, 2027 | BONGARZONE, ERNESTO ROQUE | reporter.nih.gov |
| Immunosuppression-free transplantation through placental mimicry | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,355,000 | September 14, 2021 | August 31, 2026 | WEAVER, JESSICA DIANE | reporter.nih.gov |
| Lymphatic ERG signaling in scleroderma fibrosis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,352,935 | July 7, 2022 | May 31, 2027 | TROJANOWSKA, MARIA | reporter.nih.gov |
| Multipotent ABCB5-positive cell therapeutics for corneal disease | NIH | National Eye Institute | 2021 to 2022 | $2,352,662 | April 1, 2018 | January 31, 2024 | FRANK, NATASHA Y | reporter.nih.gov |
| 3D Bioprinted Spinal Cord Organoids as a Relay System for Spinal Cord Injury | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,352,214 | September 2, 2021 | June 30, 2026 | PARR, ANN M | reporter.nih.gov |
| Intermittent fasting restores salivary gland function in Sjögren’s syndrome | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,348,947 | March 3, 2021 | February 28, 2027 | ZHOU, JING | reporter.nih.gov |
| Investigating the molecular mechanisms of HIV/AIDS associated neurological disorders using microglia and cerebral organoids derived from induced pluripotent stem cells | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,348,133 | September 1, 2019 | July 31, 2025 | RANA, TARIQ M | reporter.nih.gov |
| Replicative Potential of Muscle Stem Cells | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,347,486 | August 17, 2017 | July 31, 2027 | OLWIN, BRADLEY B | reporter.nih.gov |
| Developing a platform for human somatic cell rejuvenation, expansion and genetic engineering using synthetic RNA molecules | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,346,523 | May 1, 2021 | April 30, 2027 | KOGUT, IGOR | reporter.nih.gov |
| Myeloid sphingolipid regulation of tissue resolution and regeneration responses | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,345,752 | September 21, 2022 | July 31, 2027 | HLA, TIMOTHY TUN | reporter.nih.gov |
| Endothelial Cell Epigenetics and Blood-Brain Barrier. | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,342,216 | April 15, 2021 | February 28, 2027 | THANKAMANI PANDIT, PEEYUSH KUMAR | reporter.nih.gov |
| Retinal sheet transplant impact on functional organization of visual cortex in retinal degenerate animal models | NIH | National Eye Institute | 2022 to 2025 | $2,340,862 | May 1, 2022 | March 31, 2027 | LYON, DAVID C | reporter.nih.gov |
| 3D Encapsulation, Bioprinting and Controlled Delivery of Functionally Engineered EVs (FEEs) | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,339,586 | June 18, 2021 | May 31, 2027 | RAVINDRAN, SRIRAM | reporter.nih.gov |
| Molecular basis and protective efficacy of cross-neutralizing antibodies against four major respiratory viruses | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,338,206 | March 16, 2023 | February 29, 2028 | BOONYARATANAKORNKIT, JIM | reporter.nih.gov |
| Multi-Tissue Craniofacial Engineering using 3D-BMP9-Notch-Synergized Graphene Citrate Composite Scaffolds | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,334,479 | April 1, 2021 | January 31, 2027 | REID, RUSSELL R. | reporter.nih.gov |
| Chemotherapy-free cure of hemoglobin disorders through base editing | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,334,252 | September 1, 2023 | May 31, 2027 | BAUER, DANIEL EVAN | reporter.nih.gov |
| Regulators of epidermal growth and differentiation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,334,246 | February 17, 2015 | June 30, 2026 | SEN, GEORGE L | reporter.nih.gov |
| Efferocytosis-Directed Inflammation Resolution and Repair in the Hypoxic Heart | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,334,070 | April 1, 2014 | January 31, 2025 | THORP, EDWARD BENJAMIN | reporter.nih.gov |
| Integrated Cellular and Tissue Engineering for Ischemic Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,333,316 | September 15, 2016 | May 31, 2025 | ZHANG, JIANYI | reporter.nih.gov |
| Engineering the Vocal Fold Mucosa | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $2,331,421 | February 1, 2000 | August 31, 2027 | THIBEAULT, SUSAN LYNN | reporter.nih.gov |
| The Biology of Stem Cells in the Human Parasite Schistosoma Mansoni | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,328,971 | February 1, 2016 | January 31, 2026 | COLLINS, JAMES J | reporter.nih.gov |
| Tissue biology studies of histone modification, nascent transcription, and post-transcription regulation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,328,764 | July 1, 2018 | June 30, 2028 | TUMBAR, TUDORITA | reporter.nih.gov |
| Role of Brain Macrophages in the Pathogenesis and Treatment of Globoid Cell Leukodystrophy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,327,864 | May 3, 2021 | March 31, 2027 | BENNETT, FREDERICK | reporter.nih.gov |
| ABCB5-positive stem cells for LSCD therapy | NIH | National Eye Institute | 2023 to 2025 | $2,325,074 | June 1, 2016 | May 31, 2028 | FRANK, MARKUS H. | reporter.nih.gov |
| Nutrient-dependent regulation of neural stem cell proliferation and neural circuit formation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,324,951 | July 1, 2021 | June 30, 2027 | SIEGRIST, SARAH ELIZABETH | reporter.nih.gov |
| Bottom-Up Assembly of Functional Salivary Gland Tissues | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,324,071 | May 1, 2021 | January 31, 2027 | JIA, XINQIAO | reporter.nih.gov |
| Dynamic ECM-Mimicking Biomaterials for Ischemia Treatment | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,323,983 | December 15, 2021 | November 30, 2026 | ZOLDAN, JANETA | reporter.nih.gov |
| Novel roles for p27 as transcriptional co-regulator of cJun in stem cells and development | NIH | National Cancer Institute | 2021 to 2024 | $2,319,039 | September 1, 2020 | August 31, 2025 | SLINGERLAND, JOYCE MARIE | reporter.nih.gov |
| Chromatin-mediated mechanisms of transcription regulation in ES cells | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,316,010 | September 17, 2019 | August 31, 2029 | HAINER, SARAH JANE | reporter.nih.gov |
| The complex genetics of heart regeneration | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,315,896 | March 14, 2019 | August 31, 2027 | SUCOV, HENRY M | reporter.nih.gov |
| Pax2 Interacting Proteins in Development and Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,315,507 | January 15, 1999 | May 31, 2025 | DRESSLER, GREGORY R | reporter.nih.gov |
| Novel Intervention Approaches to Alleviate Allogeneic Transplant-Related Morbidity and Mortality | NIH | National Cancer Institute | 2021 to 2024 | $2,315,110 | September 3, 2018 | January 31, 2026 | SORROR, MOHAMED | reporter.nih.gov |
| Extrinsic Mechanisms Governing Injury-Induced Axon Degeneration | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,312,486 | August 15, 2015 | March 31, 2026 | DEPPMANN, CHRISTOPHER D | reporter.nih.gov |
| Gut microbes modulate immune pathways in intestinal stem cells to influence their lineage | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,311,160 | June 12, 2020 | May 31, 2026 | BUCHON, NICOLAS | reporter.nih.gov |
| Role of Cholecystokinin in the Dentate Gyrus | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,307,005 | June 1, 2021 | March 31, 2027 | SONG, JUAN | reporter.nih.gov |
| Investigation of the role of VEGFA in harnessing cholangiocyte-driven liver regeneration | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,306,170 | July 1, 2022 | April 30, 2027 | GOUON-EVANS, VALERIE B | reporter.nih.gov |
| Neural Stem Cell-derived EVs for Improving Aged Brain Function | NIH | National Institute on Aging | 2022 to 2025 | $2,306,114 | August 1, 2022 | April 30, 2027 | SHETTY, ASHOK K | reporter.nih.gov |
| How Patterned Mesenchymal-Epithelial interactions Shape Intestinal Crypts | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,304,272 | February 15, 2022 | January 31, 2026 | KLEIN, OPHIR D | reporter.nih.gov |
| IL-33 induced-lL-9 producing type 2 innate lymphoid cells in the regulation of acute lung injury after hematopoietic stem cell transplantation (HSCT) in pediatric patients | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,303,969 | January 1, 2022 | June 30, 2026 | PACZESNY, SOPHIE | reporter.nih.gov |
| Transplantation of MHC Homozygous Vascular Progenitors in Primates | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,302,970 | September 20, 2016 | May 31, 2025 | SLUKVIN, IGOR I. | reporter.nih.gov |
| Training In Cell and Gene Therapy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,300,213 | July 1, 2003 | July 31, 2028 | HESLOP, HELEN E | reporter.nih.gov |
| T cell invasion of the stem cell compartment during immune-mediated GI damage | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,299,846 | January 1, 2021 | December 31, 2025 | HANASH, ALAN M | reporter.nih.gov |
| Retinal Ganglion Cell Dendrite and Synapse Regeneration in Glaucoma: the Role of Insulin Signaling. | NIH | National Eye Institute | 2021 to 2024 | $2,298,831 | June 1, 2020 | May 31, 2026 | DI POLO, ADRIANA | reporter.nih.gov |
| The regulation of melanocyte stem cells by Wnt signaling | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,297,460 | August 5, 2011 | July 31, 2026 | ITO, MAYUMI | reporter.nih.gov |
| Cell Therapy for Neuroprotection in Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,294,475 | December 15, 2017 | April 30, 2027 | ISHIBASHI, NOBUYUKI | reporter.nih.gov |
| Targeted delivery of a proangiogenic and promyogenic protein for regeneration of diabetic ischemic limbs | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,288,622 | May 2, 2022 | April 30, 2027 | GUAN, JIANJUN | reporter.nih.gov |
| Endothelial tip cell-mediated angiogenesis and repair after neonatal stroke | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,288,388 | September 22, 2022 | August 31, 2027 | GONZALEZ, FERNANDO FRANCISCO | reporter.nih.gov |
| Amplification Mechanisms of Lung Endothelial Inflammation During Acute Lung Injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,286,853 | January 15, 2021 | December 31, 2025 | REHMAN, JALEES | reporter.nih.gov |
| Characterizing Human RPE Cell Proliferation to Advance Endogenous Regeneration | NIH | National Eye Institute | 2021 to 2024 | $2,286,488 | February 1, 2021 | November 30, 2025 | TEMPLE, SALLY | reporter.nih.gov |
| Biomechanical Determinants of Hematopoietic Stem Cell Potential | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,282,783 | January 15, 2018 | November 30, 2026 | WENZEL, PAMELA LYNN | reporter.nih.gov |
| A Novel Semi-autonomous Surgeon-in-the-loop in situ Robotic Bioprinting System for Functional and Cosmetic Restoration of Volumetric Muscle Loss Injuries | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,279,838 | September 1, 2022 | August 31, 2027 | ALAMBEIGI, FARSHID | reporter.nih.gov |
| Transcriptional Regulation of Lung Alveolar Regeneration | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,270,370 | February 1, 2021 | December 31, 2024 | MORRISEY, EDWARD E | reporter.nih.gov |
| Tapeworm stem cells as drivers of regeneration and reproduction | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,265,000 | March 5, 2021 | February 28, 2027 | ROZARIO, TANIA | reporter.nih.gov |
| Biostimulatory nanofiber-hydrogel composite for soft tissue remodeling | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $2,263,220 | February 1, 2022 | January 31, 2027 | REDDY, SASHANK K | reporter.nih.gov |
| Understanding the role of stellate cells in the liver hematopoietic stem cell niche | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,262,921 | August 1, 2020 | July 31, 2025 | DING, LEI | reporter.nih.gov |
| Exploring networks underlying muscle stem cell identity - Resubmission - 1 | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,259,735 | June 1, 2021 | May 31, 2027 | DYNLACHT, BRIAN D | reporter.nih.gov |
| High resolution lineage tracing of developmental hematopoiesis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,256,385 | May 5, 2023 | February 28, 2027 | CAMARGO, FERNANDO | reporter.nih.gov |
| Harnessing Platelet-Endothelial Interactions for Exosome Delivery | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,253,989 | April 1, 2019 | July 31, 2027 | CHENG, KE | reporter.nih.gov |
| A stem cell activated cryogel bioscaffold that restores islet bioenergetics while providing oxygen and nutrients at extravascular sites of transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,251,861 | April 1, 2022 | March 31, 2027 | THAKOR, AVNESH SINH | reporter.nih.gov |
| Elution of a Small Molecule from a Bio Ceramic Collagen Bone Graft Device Heals Bone while InhibitingBreast Cancer Bone Metastases | NIH | National Cancer Institute | 2021 to 2022 | $2,249,777 | November 30, 2021 | August 31, 2022 | MARGULIES, BRYAN SAMUEL | reporter.nih.gov |
| Diversity Supplement to R01 DC018042 | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $2,249,478 | April 1, 2021 | March 31, 2025 | WANG, HONG | reporter.nih.gov |
| Transcriptional Control of Neonatal Heart Regeneration | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,248,844 | December 6, 2021 | November 30, 2025 | OLSON, ERIC N | reporter.nih.gov |
| Gaze recovery during vestibular regeneration | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $2,240,600 | December 1, 2020 | November 30, 2026 | DICKMAN, J DAVID | reporter.nih.gov |
| Arthroscopic Raman Monitoring of Cartilage Content for PTOA Diagnosis and Chondroregenerative Treatment Response | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,239,693 | August 2, 2022 | May 31, 2027 | ALBRO, MICHAEL B | reporter.nih.gov |
| Targeting a ectonucleotidase in the heart with a monoclonal antibody to prevent post-infarct heart failure | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,239,092 | August 14, 2023 | June 30, 2027 | DEB, ARJUN | reporter.nih.gov |
| Molecular mechanisms mediating the soft tissue attachment to teeth | NIH | National Institute of Dental & Craniofacial Research | 2023 to 2025 | $2,238,127 | February 20, 2023 | January 31, 2028 | HELMS, JILL A | reporter.nih.gov |
| Blockade of IL-23 for the Prevention of Graft Versus Host Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,237,924 | April 15, 2021 | March 31, 2026 | DROBYSKI, WILLIAM R. | reporter.nih.gov |
| Contribution of macrophages in the HSC niche | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,230,269 | April 1, 2021 | February 28, 2026 | STEIDL, ULRICH | reporter.nih.gov |
| Intraoperative bioprinting of composite tissues with zonal stratification for craniomaxillofacial reconstruction | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $2,227,502 | January 1, 2020 | December 31, 2025 | OZBOLAT, IBRAHIM | reporter.nih.gov |
| Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,221,837 | May 2, 2022 | April 30, 2027 | NGUYEN, KYTAI TRUONG | reporter.nih.gov |
| Multiplex base/prime editors for in vivo selection of modified HSPCs in hemoglobinopathy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $2,218,334 | January 17, 2017 | December 31, 2025 | KIEM, HANS-PETER | reporter.nih.gov |
| Molecular and Genetic Analysis of Fin Regeneration in Zebrafish | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,217,522 | July 1, 2020 | May 31, 2030 | KANG, JUNSU | reporter.nih.gov |
| Intra-graft C1 esterase inhibitor therapy for deceased kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $2,216,525 | September 1, 2024 | August 31, 2031 | HEEGER, PETER SCOTT | reporter.nih.gov |
| Intra-graft C1 esterase inhibitor therapy for deceased kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $2,216,525 | September 1, 2024 | August 31, 2031 | HEEGER, PETER SCOTT | reporter.nih.gov |
| Microenvironmental Control of Capillary Morphogenesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,216,157 | July 20, 2007 | March 31, 2026 | PUTNAM, ANDREW J | reporter.nih.gov |
| Notch signaling and Bone Fracture Healing | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,213,436 | February 1, 2011 | January 31, 2027 | KALAJZIC, IVO | reporter.nih.gov |
| Inhibition of STAT3 and inflammatory cytokine production | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,211,650 | September 30, 1999 | January 31, 2027 | IVASHKIV, LIONEL B | reporter.nih.gov |
| Strain-Programmed Bioadhesive Patch for Enhanced Diabetic Wound Healing | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $2,210,864 | September 7, 2023 | August 31, 2025 | YUK, HYUNWOO | reporter.nih.gov |
| Developmental Heterogeneity of Pulmonary Endothelial Phenotype at Single Cell Resolution | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,206,652 | September 15, 2021 | December 1, 2024 | ALVIRA, CRISTINA MARIA | reporter.nih.gov |
| Progenitor cell states contributing to aging and lung cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,206,534 | September 24, 2021 | August 31, 2026 | HAIGIS, MARCIA | reporter.nih.gov |
| Enhancing endothelial cell engraftment via transplantation of exogenous mitochondria | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,206,197 | December 20, 2020 | November 30, 2024 | MELERO-MARTIN, JUAN M | reporter.nih.gov |
| Engineering the Stem Cell Microenvironment for Lymphatic Regeneration | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,205,356 | July 1, 2021 | May 31, 2027 | HANJAYA-PUTRA, DONNY | reporter.nih.gov |
| Variant Determinants of African American Limb Pathology in Peripheral Arterial Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,205,005 | April 1, 2021 | August 1, 2024 | MCCLUNG, JOSEPH MATTHEW | reporter.nih.gov |
| Comparison of normal aging with Alzheimer's Disease: cellular, synaptic, and vascular indices affecting brain plasticity and neurogenesis | NIH | National Institute on Aging | 2023 to 2025 | $2,205,002 | September 21, 2023 | May 31, 2028 | DUPONT, MAURA BOLDRINI | reporter.nih.gov |
| Mineralized collagen composite to accelerate craniofacial bone regeneration | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $2,203,403 | May 3, 2021 | April 30, 2027 | HARLEY, BRENDAN A. | reporter.nih.gov |
| Coordinated regeneration of lung epithelial and endothelial compartments | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,201,693 | August 20, 2022 | July 31, 2026 | VAUGHAN, ANDREW | reporter.nih.gov |
| Ex-vivo bioengineered technology to unravel dysfunction due to non-alcoholic steatohepatitis (NASH) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,201,102 | July 1, 2023 | April 30, 2027 | WERTHEIM, JASON A | reporter.nih.gov |
| Mechanism of action of PTH: New signaling components that regulate bone formation and bone marrow fat | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,199,383 | May 5, 2020 | March 31, 2026 | BARON, ROLAND E | reporter.nih.gov |
| Biology of Submucosal Gland Stem Cells in the Airway | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $2,198,254 | June 20, 2022 | May 31, 2025 | ENGELHARDT, JOHN F | reporter.nih.gov |
| Strategies to Enhance Engineered Heart Tissue Based Myocardial Repair | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,196,794 | January 1, 2023 | November 30, 2026 | ZHU, WUQIANG | reporter.nih.gov |
| Role of Stress Granule Protein Aggregation in Axon Regeneration | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,196,651 | July 1, 2020 | June 30, 2026 | TWISS, JEFFERY L | reporter.nih.gov |
| Pathways underlying recovery of injured urethral sphincter and a novel regenerative biomaterial intervention | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,191,647 | July 15, 2021 | April 30, 2026 | ALPERIN, MARIANNA | reporter.nih.gov |
| Functional and histological changes to peripheral innervation following spinal cord stimulation in patients with painful diabetic neuropathy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,189,785 | September 12, 2023 | July 31, 2028 | TOWNSEND, KRISTY L | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Stanford University | Stanford, CA | 146 | $136.1 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 107 | $118.4 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 117 | $113.7 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 99 | $108.7 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 34 | $103.8 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 77 | $94.4 million | 0 | $0 |
| Duke University | Durham, NC | 89 | $94.1 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 54 | $90.6 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 64 | $90.4 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 90 | $86.6 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 72 | $83.3 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 90 | $79.9 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 44 | $68.7 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 71 | $65.3 million | 0 | $0 |
| University of Washington | Seattle, WA | 70 | $63.9 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 57 | $63.7 million | 0 | $0 |
| Fred Hutchinson Cancer Center | Seattle, WA | 35 | $60.7 million | 0 | $0 |
| Washington University | Saint Louis, MO | 66 | $60 million | 0 | $0 |
| Yale University | New Haven, CT | 50 | $54 million | 0 | $0 |
| Emory University | Atlanta, GA | 55 | $53.8 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 52 | $53.6 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 39 | $52.7 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 40 | $50.7 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 53 | $48.5 million | 0 | $0 |
| Ohio State University | Columbus, OH | 48 | $47.5 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 47 | $46.7 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 33 | $46.4 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 36 | $46.2 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 42 | $45.5 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 37 | $44 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 47 | $41.9 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 13 | $41.5 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 34 | $40.9 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 51 | $36.7 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 28 | $36 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 27 | $34.3 million | 0 | $0 |
| Beckman Research Institute/city of Hope | Duarte, CA | 18 | $33.4 million | 0 | $0 |
| Sloan-Kettering Inst Can Research | New York, NY | 25 | $32.7 million | 0 | $0 |
| Temple Univ of the Commonwealth | Philadelphia, PA | 28 | $32.2 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 26 | $31.6 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 33 | $28.9 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 29 | $28.9 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 20 | $28.7 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 22 | $27.7 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 25 | $27.7 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 24 | $27.7 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 32 | $27.4 million | 0 | $0 |
| University of California at Davis | Davis, CA | 36 | $27.2 million | 0 | $0 |
| Harvard University | Cambridge, MA | 32 | $26.1 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 27 | $26.1 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 30 | $25.1 million | 0 | $0 |
| University of Rochester | Rochester, NY | 25 | $24.7 million | 0 | $0 |
| University of Florida | Gainesville, FL | 30 | $24.5 million | 0 | $0 |
| Cornell University | Ithaca, NY | 20 | $24.5 million | 0 | $0 |
| Regents of the University of Idaho | Moscow, ID | 2 | $23.4 million | 0 | $0 |
| Georgia Tech Research Corporation | Atlanta, GA | 28 | $23.1 million | 0 | $0 |
| Boston University Medical Campus | Boston, MA | 30 | $21.4 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 18 | $20.6 million | 0 | $0 |
| Research Inst Nationwide Children's Hosp | Columbus, OH | 18 | $20.6 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 24 | $20.5 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 23 | $19.1 million | 0 | $0 |
| University of Connecticut SCH of Med/dnt | Farmington, CT | 24 | $18.8 million | 0 | $0 |
| University of Colorado at Boulder | Boulder, CO | 14 | $18.8 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 19 | $18.7 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 14 | $18.6 million | 0 | $0 |
| Massachusetts Institute of Technology | Cambridge, MA | 17 | $18.4 million | 0 | $0 |
| University of Illinois at Urbana-Champaign | Urbana, IL | 14 | $18.3 million | 0 | $0 |
| Pennsylvania State Univ University Park | University Park, PA | 17 | $17.9 million | 0 | $0 |
| University of Cincinnati | Cincinnati, OH | 18 | $17.6 million | 0 | $0 |
| University of Oregon Eugene | Eugene, OR | 23 | $17.5 million | 0 | $0 |
| Columbia University | New York, NY | 15 | $17.2 million | 0 | $0 |
| Lurie Children's Hospital of Chicago | Chicago, IL | 11 | $16.6 million | 0 | $0 |
| Harvard Medical School | Boston, MA | 22 | $16.6 million | 0 | $0 |
| University of Missouri-Columbia | Columbia, MO | 22 | $16.5 million | 0 | $0 |
| Methodist Hospital Research Institute | Houston, TX | 10 | $16.2 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 21 | $16.2 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 14 | $15.8 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 14 | $15.6 million | 0 | $0 |
| University of California-Berkeley | Berkeley, CA | 15 | $15.5 million | 0 | $0 |
| National Jewish Health | Denver, CO | 10 | $15.3 million | 0 | $0 |
| Texas A&m University Health Science CTR | College Station, TX | 19 | $15.2 million | 0 | $0 |
| North Carolina State University | Raleigh, NC | 15 | $15.1 million | 0 | $0 |
| Tufts University Boston | Boston, MA | 14 | $15 million | 0 | $0 |
| ST. Jude Children's Research Hospital | Memphis, TN | 15 | $14.8 million | 0 | $0 |
| Northwestern University | Chicago, IL | 15 | $14.7 million | 0 | $0 |
| Tulane University of Louisiana | New Orleans, LA | 12 | $14.7 million | 0 | $0 |
| University of Texas at Austin | Austin, TX | 18 | $14.5 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 13 | $14.3 million | 0 | $0 |
| University of Louisville | Louisville, KY | 17 | $14.3 million | 0 | $0 |
| Trustees of Boston University | Boston, MA | 17 | $13.5 million | 0 | $0 |
| Michigan State University | East Lansing, MI | 14 | $13.3 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 7 | $13.2 million | 0 | $0 |
| Sanford Burnham Prebys Medical Discovery Institute | La Jolla, CA | 10 | $12.9 million | 0 | $0 |
| Purdue University | West Lafayette, IN | 13 | $12.3 million | 0 | $0 |
| University of TX MD Anderson Can CTR | Houston, TX | 11 | $12.2 million | 0 | $0 |
| University of Georgia Research Foundation Inc | Athens, GA | 11 | $12 million | 0 | $0 |
| University of South Florida | Tampa, FL | 10 | $11.8 million | 0 | $0 |
| Regenerative Research Foundation | Albany, NY | 7 | $11.7 million | 0 | $0 |
| Rutgers University New Brunswick | New Brunswick, NJ | 12 | $11.6 million | 0 | $0 |
| Mayo Clinic Arizona | Scottsdale, AZ | 6 | $11 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 1,894 | $919,615,811 | 0 | $0 |
| 2024 | 1,996 | $904,939,152 | 0 | $0 |
| 2023 | 2,087 | $922,399,775 | 0 | $0 |
| 2022 | 2,092 | $890,511,065 | 0 | $0 |
| 2021 | 2,132 | $897,338,534 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.